ES2341441T3 - ORGANOSILICIDE DERIVATIVES OF AMINO HIDROXIBENZOFENONAS AND ITS USE AS FILTERS OF UV-A RAYS IN COSMETIC PREPARATIONS. - Google Patents
ORGANOSILICIDE DERIVATIVES OF AMINO HIDROXIBENZOFENONAS AND ITS USE AS FILTERS OF UV-A RAYS IN COSMETIC PREPARATIONS. Download PDFInfo
- Publication number
- ES2341441T3 ES2341441T3 ES03746278T ES03746278T ES2341441T3 ES 2341441 T3 ES2341441 T3 ES 2341441T3 ES 03746278 T ES03746278 T ES 03746278T ES 03746278 T ES03746278 T ES 03746278T ES 2341441 T3 ES2341441 T3 ES 2341441T3
- Authority
- ES
- Spain
- Prior art keywords
- formula
- derivatives
- acid
- group
- organosilicon compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 26
- 238000002360 preparation method Methods 0.000 title claims abstract description 19
- -1 AMINO Chemical class 0.000 title claims description 72
- 239000000203 mixture Substances 0.000 claims abstract description 78
- 210000004209 hair Anatomy 0.000 claims abstract description 16
- 238000000034 method Methods 0.000 claims abstract description 7
- 150000003961 organosilicon compounds Chemical class 0.000 claims description 28
- 150000001875 compounds Chemical class 0.000 claims description 23
- 229920000642 polymer Polymers 0.000 claims description 13
- 230000004224 protection Effects 0.000 claims description 11
- 229920006395 saturated elastomer Polymers 0.000 claims description 11
- 239000001257 hydrogen Substances 0.000 claims description 10
- 229910052739 hydrogen Inorganic materials 0.000 claims description 10
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 10
- SNOOUWRIMMFWNE-UHFFFAOYSA-M sodium;6-[(3,4,5-trimethoxybenzoyl)amino]hexanoate Chemical compound [Na+].COC1=CC(C(=O)NCCCCCC([O-])=O)=CC(OC)=C1OC SNOOUWRIMMFWNE-UHFFFAOYSA-M 0.000 claims description 10
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 9
- 125000000217 alkyl group Chemical group 0.000 claims description 7
- 239000000654 additive Substances 0.000 claims description 5
- 239000002671 adjuvant Substances 0.000 claims description 5
- 125000002947 alkylene group Chemical group 0.000 claims description 5
- 125000000392 cycloalkenyl group Chemical group 0.000 claims description 5
- 230000000699 topical effect Effects 0.000 claims description 5
- 125000004450 alkenylene group Chemical group 0.000 claims description 4
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 4
- 238000006459 hydrosilylation reaction Methods 0.000 claims description 4
- 125000003358 C2-C20 alkenyl group Chemical group 0.000 claims description 2
- 229910052757 nitrogen Inorganic materials 0.000 claims description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 2
- 125000001183 hydrocarbyl group Chemical group 0.000 claims 3
- DRAKOGLGKMMYMG-UHFFFAOYSA-N (3-amino-2-hydroxyphenyl)-phenylmethanone Chemical class NC1=CC=CC(C(=O)C=2C=CC=CC=2)=C1O DRAKOGLGKMMYMG-UHFFFAOYSA-N 0.000 abstract description 4
- 239000002253 acid Substances 0.000 description 32
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 21
- 150000002148 esters Chemical class 0.000 description 20
- 210000003491 skin Anatomy 0.000 description 17
- 239000003921 oil Substances 0.000 description 16
- 235000019198 oils Nutrition 0.000 description 16
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 15
- 239000000047 product Substances 0.000 description 14
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid group Chemical group C(C1=CC=CC=C1)(=O)O WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 12
- 230000005855 radiation Effects 0.000 description 12
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 10
- 150000003839 salts Chemical class 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 239000003995 emulsifying agent Substances 0.000 description 9
- 238000009472 formulation Methods 0.000 description 9
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 8
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- 239000006071 cream Substances 0.000 description 8
- 239000000839 emulsion Substances 0.000 description 8
- 235000019441 ethanol Nutrition 0.000 description 8
- 239000000499 gel Substances 0.000 description 8
- 229920001296 polysiloxane Polymers 0.000 description 8
- KWYUFKZDYYNOTN-UHFFFAOYSA-M potassium hydroxide Inorganic materials [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 8
- 230000000475 sunscreen effect Effects 0.000 description 8
- 239000000516 sunscreening agent Substances 0.000 description 8
- 229910052721 tungsten Inorganic materials 0.000 description 8
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 7
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 7
- 229920001577 copolymer Polymers 0.000 description 7
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 7
- 150000002430 hydrocarbons Chemical group 0.000 description 7
- 229960001679 octinoxate Drugs 0.000 description 7
- 239000011814 protection agent Substances 0.000 description 7
- 239000011734 sodium Substances 0.000 description 7
- 239000000600 sorbitol Substances 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- XXROGKLTLUQVRX-UHFFFAOYSA-N allyl alcohol Chemical compound OCC=C XXROGKLTLUQVRX-UHFFFAOYSA-N 0.000 description 6
- UPOYFZYFGWBUKL-UHFFFAOYSA-N amiphenazole Chemical compound S1C(N)=NC(N)=C1C1=CC=CC=C1 UPOYFZYFGWBUKL-UHFFFAOYSA-N 0.000 description 6
- 229950001798 amiphenazole Drugs 0.000 description 6
- 239000003963 antioxidant agent Substances 0.000 description 6
- 235000006708 antioxidants Nutrition 0.000 description 6
- 239000003974 emollient agent Substances 0.000 description 6
- 239000006210 lotion Substances 0.000 description 6
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 5
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 5
- 239000004909 Moisturizer Substances 0.000 description 5
- 150000001298 alcohols Chemical class 0.000 description 5
- 125000004432 carbon atom Chemical group C* 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 239000003792 electrolyte Substances 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 230000001333 moisturizer Effects 0.000 description 5
- 229910052760 oxygen Inorganic materials 0.000 description 5
- 235000013772 propylene glycol Nutrition 0.000 description 5
- 239000003223 protective agent Substances 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 239000001993 wax Substances 0.000 description 5
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 4
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 150000002170 ethers Chemical class 0.000 description 4
- 235000019439 ethyl acetate Nutrition 0.000 description 4
- 150000004665 fatty acids Chemical class 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 239000004530 micro-emulsion Substances 0.000 description 4
- 125000005375 organosiloxane group Chemical group 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 239000012071 phase Substances 0.000 description 4
- 239000000049 pigment Substances 0.000 description 4
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 230000001681 protective effect Effects 0.000 description 4
- 229940083542 sodium Drugs 0.000 description 4
- 235000015424 sodium Nutrition 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 125000001424 substituent group Chemical group 0.000 description 4
- 229910019142 PO4 Inorganic materials 0.000 description 3
- 239000004264 Petrolatum Substances 0.000 description 3
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229920002125 Sokalan® Polymers 0.000 description 3
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 229910052782 aluminium Inorganic materials 0.000 description 3
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 3
- 235000010210 aluminium Nutrition 0.000 description 3
- 239000012298 atmosphere Substances 0.000 description 3
- 239000004359 castor oil Substances 0.000 description 3
- 235000019438 castor oil Nutrition 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- NZZIMKJIVMHWJC-UHFFFAOYSA-N dibenzoylmethane Chemical class C=1C=CC=CC=1C(=O)CC(=O)C1=CC=CC=C1 NZZIMKJIVMHWJC-UHFFFAOYSA-N 0.000 description 3
- 239000004205 dimethyl polysiloxane Substances 0.000 description 3
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 3
- 239000000975 dye Substances 0.000 description 3
- 239000006260 foam Substances 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 3
- 239000003906 humectant Substances 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 229960004592 isopropanol Drugs 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 229910044991 metal oxide Inorganic materials 0.000 description 3
- 150000004706 metal oxides Chemical class 0.000 description 3
- 239000002480 mineral oil Substances 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 3
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 3
- 235000019271 petrolatum Nutrition 0.000 description 3
- 229940066842 petrolatum Drugs 0.000 description 3
- 239000010452 phosphate Substances 0.000 description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 3
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 3
- 229920005862 polyol Polymers 0.000 description 3
- 150000003077 polyols Chemical class 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 239000002562 thickening agent Substances 0.000 description 3
- OIQXFRANQVWXJF-QBFSEMIESA-N (2z)-2-benzylidene-4,7,7-trimethylbicyclo[2.2.1]heptan-3-one Chemical compound CC1(C)C2CCC1(C)C(=O)\C2=C/C1=CC=CC=C1 OIQXFRANQVWXJF-QBFSEMIESA-N 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical class C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 2
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 2
- WAYINTBTZWQNSN-UHFFFAOYSA-N 11-methyldodecyl 3,5,5-trimethylhexanoate Chemical compound CC(C)CCCCCCCCCCOC(=O)CC(C)CC(C)(C)C WAYINTBTZWQNSN-UHFFFAOYSA-N 0.000 description 2
- UEASUBCMCWNOJA-UHFFFAOYSA-N 2-[4-(diethylamino)-2-hydroxybenzoyl]benzamide Chemical compound OC1=CC(N(CC)CC)=CC=C1C(=O)C1=CC=CC=C1C(N)=O UEASUBCMCWNOJA-UHFFFAOYSA-N 0.000 description 2
- FQNKTJPBXAZUGC-UHFFFAOYSA-N 2-[4-(diethylamino)-2-hydroxybenzoyl]benzoic acid Chemical compound OC1=CC(N(CC)CC)=CC=C1C(=O)C1=CC=CC=C1C(O)=O FQNKTJPBXAZUGC-UHFFFAOYSA-N 0.000 description 2
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 2
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 description 2
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 description 2
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 2
- 241000723346 Cinnamomum camphora Species 0.000 description 2
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 2
- ZDQWESQEGGJUCH-UHFFFAOYSA-N Diisopropyl adipate Chemical compound CC(C)OC(=O)CCCCC(=O)OC(C)C ZDQWESQEGGJUCH-UHFFFAOYSA-N 0.000 description 2
- FMRHJJZUHUTGKE-UHFFFAOYSA-N Ethylhexyl salicylate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1O FMRHJJZUHUTGKE-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- LEEDMQGKBNGPDN-UHFFFAOYSA-N Isoeicosane Natural products CCCCCCCCCCCCCCCCCC(C)C LEEDMQGKBNGPDN-UHFFFAOYSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- CQOVPNPJLQNMDC-UHFFFAOYSA-N N-beta-alanyl-L-histidine Natural products NCCC(=O)NC(C(O)=O)CC1=CN=CN1 CQOVPNPJLQNMDC-UHFFFAOYSA-N 0.000 description 2
- 239000007832 Na2SO4 Substances 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- 235000019486 Sunflower oil Nutrition 0.000 description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
- 239000004904 UV filter Substances 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- DSVGQVZAZSZEEX-UHFFFAOYSA-N [C].[Pt] Chemical compound [C].[Pt] DSVGQVZAZSZEEX-UHFFFAOYSA-N 0.000 description 2
- 150000001343 alkyl silanes Chemical class 0.000 description 2
- ANVAOWXLWRTKGA-XHGAXZNDSA-N all-trans-alpha-carotene Chemical compound CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1C(C)=CCCC1(C)C ANVAOWXLWRTKGA-XHGAXZNDSA-N 0.000 description 2
- 235000011399 aloe vera Nutrition 0.000 description 2
- CEGOLXSVJUTHNZ-UHFFFAOYSA-K aluminium tristearate Chemical compound [Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CEGOLXSVJUTHNZ-UHFFFAOYSA-K 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 229960004050 aminobenzoic acid Drugs 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 235000013871 bee wax Nutrition 0.000 description 2
- 239000012166 beeswax Substances 0.000 description 2
- JAEJSNFTJMYIEF-UHFFFAOYSA-L benzylmalonate group Chemical group C(C1=CC=CC=C1)C(C(=O)[O-])C(=O)[O-] JAEJSNFTJMYIEF-UHFFFAOYSA-L 0.000 description 2
- DSVRVHYFPPQFTI-UHFFFAOYSA-N bis(ethenyl)-methyl-trimethylsilyloxysilane;platinum Chemical compound [Pt].C[Si](C)(C)O[Si](C)(C=C)C=C DSVRVHYFPPQFTI-UHFFFAOYSA-N 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 229960000846 camphor Drugs 0.000 description 2
- 229930008380 camphor Natural products 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 150000001735 carboxylic acids Chemical class 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 125000002091 cationic group Chemical group 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 235000019868 cocoa butter Nutrition 0.000 description 2
- 229940110456 cocoa butter Drugs 0.000 description 2
- 229940071160 cocoate Drugs 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- 229940086555 cyclomethicone Drugs 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- 238000007872 degassing Methods 0.000 description 2
- 229940031766 diethanolamine cetyl phosphate Drugs 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 150000002191 fatty alcohols Chemical class 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 230000009931 harmful effect Effects 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- ZUVCYFMOHFTGDM-UHFFFAOYSA-N hexadecyl dihydrogen phosphate Chemical compound CCCCCCCCCCCCCCCCOP(O)(O)=O ZUVCYFMOHFTGDM-UHFFFAOYSA-N 0.000 description 2
- GKKMCECQQIKAHA-UHFFFAOYSA-N hexadecyl dihydrogen phosphate;2-(2-hydroxyethylamino)ethanol Chemical compound OCCNCCO.CCCCCCCCCCCCCCCCOP(O)(O)=O GKKMCECQQIKAHA-UHFFFAOYSA-N 0.000 description 2
- 229920001519 homopolymer Polymers 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 229940100554 isononyl isononanoate Drugs 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- SWGZAKPJNWCPRY-UHFFFAOYSA-N methyl-bis(trimethylsilyloxy)silicon Chemical compound C[Si](C)(C)O[Si](C)O[Si](C)(C)C SWGZAKPJNWCPRY-UHFFFAOYSA-N 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 239000002777 nucleoside Substances 0.000 description 2
- 125000003835 nucleoside group Chemical group 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical compound C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 description 2
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- OQILCOQZDHPEAZ-UHFFFAOYSA-N octyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- BARWIPMJPCRCTP-CLFAGFIQSA-N oleyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC BARWIPMJPCRCTP-CLFAGFIQSA-N 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- 150000002894 organic compounds Chemical class 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical class [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 2
- 230000003711 photoprotective effect Effects 0.000 description 2
- 229910052697 platinum Inorganic materials 0.000 description 2
- 229940056099 polyglyceryl-4 oleate Drugs 0.000 description 2
- 229920000098 polyolefin Polymers 0.000 description 2
- 229920001451 polypropylene glycol Polymers 0.000 description 2
- 229920002282 polysilicones-15 Polymers 0.000 description 2
- RMGVATURDVPNOZ-UHFFFAOYSA-M potassium;hexadecyl hydrogen phosphate Chemical compound [K+].CCCCCCCCCCCCCCCCOP(O)([O-])=O RMGVATURDVPNOZ-UHFFFAOYSA-M 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- TVDSBUOJIPERQY-UHFFFAOYSA-N prop-2-yn-1-ol Chemical compound OCC#C TVDSBUOJIPERQY-UHFFFAOYSA-N 0.000 description 2
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 2
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 2
- 229960004555 rutoside Drugs 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 2
- 229960001860 salicylate Drugs 0.000 description 2
- 239000012047 saturated solution Substances 0.000 description 2
- 239000002453 shampoo Substances 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Inorganic materials [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000002600 sunflower oil Substances 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- 229920002554 vinyl polymer Polymers 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 2
- 229910000368 zinc sulfate Inorganic materials 0.000 description 2
- 229910001928 zirconium oxide Inorganic materials 0.000 description 2
- HEOCBCNFKCOKBX-RELGSGGGSA-N (1s,2e,4r)-4,7,7-trimethyl-2-[(4-methylphenyl)methylidene]bicyclo[2.2.1]heptan-3-one Chemical compound C1=CC(C)=CC=C1\C=C/1C(=O)[C@]2(C)CC[C@H]\1C2(C)C HEOCBCNFKCOKBX-RELGSGGGSA-N 0.000 description 1
- HJIAMFHSAAEUKR-UHFFFAOYSA-N (2-hydroxyphenyl)-phenylmethanone Chemical group OC1=CC=CC=C1C(=O)C1=CC=CC=C1 HJIAMFHSAAEUKR-UHFFFAOYSA-N 0.000 description 1
- DBSABEYSGXPBTA-RXSVEWSESA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;phosphoric acid Chemical compound OP(O)(O)=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O DBSABEYSGXPBTA-RXSVEWSESA-N 0.000 description 1
- LUKQUIZLFXGUKZ-UHFFFAOYSA-N (3-benzylidene-1,7,7-trimethyl-2-oxo-4-bicyclo[2.2.1]heptanyl)methanesulfonic acid Chemical compound CC1(C)C(C2=O)(C)CCC1(CS(O)(=O)=O)C2=CC1=CC=CC=C1 LUKQUIZLFXGUKZ-UHFFFAOYSA-N 0.000 description 1
- NRTKYSGFUISGRQ-UHFFFAOYSA-N (3-heptanoyloxy-2,2-dimethylpropyl) heptanoate Chemical compound CCCCCCC(=O)OCC(C)(C)COC(=O)CCCCCC NRTKYSGFUISGRQ-UHFFFAOYSA-N 0.000 description 1
- MEJYDZQQVZJMPP-ULAWRXDQSA-N (3s,3ar,6r,6ar)-3,6-dimethoxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan Chemical compound CO[C@H]1CO[C@@H]2[C@H](OC)CO[C@@H]21 MEJYDZQQVZJMPP-ULAWRXDQSA-N 0.000 description 1
- AALXZHPCKJILAZ-UHFFFAOYSA-N (4-propan-2-ylphenyl)methyl 2-hydroxybenzoate Chemical compound C1=CC(C(C)C)=CC=C1COC(=O)C1=CC=CC=C1O AALXZHPCKJILAZ-UHFFFAOYSA-N 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- YKYIFUROKBDHCY-ONEGZZNKSA-N (e)-4-ethoxy-1,1,1-trifluorobut-3-en-2-one Chemical group CCO\C=C\C(=O)C(F)(F)F YKYIFUROKBDHCY-ONEGZZNKSA-N 0.000 description 1
- 125000001140 1,4-phenylene group Chemical group [H]C1=C([H])C([*:2])=C([H])C([H])=C1[*:1] 0.000 description 1
- RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- LALVCWMSKLEQMK-UHFFFAOYSA-N 1-phenyl-3-(4-propan-2-ylphenyl)propane-1,3-dione Chemical compound C1=CC(C(C)C)=CC=C1C(=O)CC(=O)C1=CC=CC=C1 LALVCWMSKLEQMK-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 description 1
- BEXQNGUXPFGRDC-UHFFFAOYSA-N 2,2-dimethoxy-1,3-diphenylpropane-1,3-dione Chemical compound C=1C=CC=CC=1C(=O)C(OC)(OC)C(=O)C1=CC=CC=C1 BEXQNGUXPFGRDC-UHFFFAOYSA-N 0.000 description 1
- WHQOKFZWSDOTQP-UHFFFAOYSA-N 2,3-dihydroxypropyl 4-aminobenzoate Chemical compound NC1=CC=C(C(=O)OCC(O)CO)C=C1 WHQOKFZWSDOTQP-UHFFFAOYSA-N 0.000 description 1
- SBASXUCJHJRPEV-UHFFFAOYSA-N 2-(2-methoxyethoxy)ethanol Chemical group COCCOCCO SBASXUCJHJRPEV-UHFFFAOYSA-N 0.000 description 1
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 1
- IUVCFHHAEHNCFT-INIZCTEOSA-N 2-[(1s)-1-[4-amino-3-(3-fluoro-4-propan-2-yloxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]ethyl]-6-fluoro-3-(3-fluorophenyl)chromen-4-one Chemical compound C1=C(F)C(OC(C)C)=CC=C1C(C1=C(N)N=CN=C11)=NN1[C@@H](C)C1=C(C=2C=C(F)C=CC=2)C(=O)C2=CC(F)=CC=C2O1 IUVCFHHAEHNCFT-INIZCTEOSA-N 0.000 description 1
- LAXXPOJCFVMVAX-UHFFFAOYSA-N 2-azaniumyl-4-butylsulfanylbutanoate Chemical compound CCCCSCCC(N)C(O)=O LAXXPOJCFVMVAX-UHFFFAOYSA-N 0.000 description 1
- KXTAOXNYQGASTA-UHFFFAOYSA-N 2-benzylidenepropanedioic acid Chemical compound OC(=O)C(C(O)=O)=CC1=CC=CC=C1 KXTAOXNYQGASTA-UHFFFAOYSA-N 0.000 description 1
- OSJVRHJQUTTZIN-UHFFFAOYSA-N 2-ethoxyethyl 2-methoxy-3-phenylprop-2-enoate Chemical compound CCOCCOC(=O)C(OC)=CC1=CC=CC=C1 OSJVRHJQUTTZIN-UHFFFAOYSA-N 0.000 description 1
- DURPSQKXVZOHKI-UHFFFAOYSA-N 2-ethoxyphenol;5-methoxy-4-phenyltriazine Chemical compound CCOC1=CC=CC=C1O.COC1=CN=NN=C1C1=CC=CC=C1 DURPSQKXVZOHKI-UHFFFAOYSA-N 0.000 description 1
- JGUMTYWKIBJSTN-UHFFFAOYSA-N 2-ethylhexyl 4-[[4,6-bis[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 JGUMTYWKIBJSTN-UHFFFAOYSA-N 0.000 description 1
- SFAAOBGYWOUHLU-UHFFFAOYSA-N 2-ethylhexyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CC)CCCC SFAAOBGYWOUHLU-UHFFFAOYSA-N 0.000 description 1
- MWKPHOIHTLQZIY-UHFFFAOYSA-N 2-hexyldecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(CCCCCC)CCCCCCCC MWKPHOIHTLQZIY-UHFFFAOYSA-N 0.000 description 1
- BANXPJUEBPWEOT-UHFFFAOYSA-N 2-methyl-Pentadecane Chemical class CCCCCCCCCCCCCC(C)C BANXPJUEBPWEOT-UHFFFAOYSA-N 0.000 description 1
- RUDXBXPTJPNTSO-UHFFFAOYSA-N 2-octyldodecyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC RUDXBXPTJPNTSO-UHFFFAOYSA-N 0.000 description 1
- QMIBDVOQOZDSEN-UHFFFAOYSA-N 2-phenylbenzimidazole-2-sulfonic acid Chemical compound N1=C2C=CC=CC2=NC1(S(=O)(=O)O)C1=CC=CC=C1 QMIBDVOQOZDSEN-UHFFFAOYSA-N 0.000 description 1
- WMJBVALTYVXGHW-UHFFFAOYSA-N 3,3-diphenylprop-2-enoic acid Chemical compound C=1C=CC=CC=1C(=CC(=O)O)C1=CC=CC=C1 WMJBVALTYVXGHW-UHFFFAOYSA-N 0.000 description 1
- QJZYHAIUNVAGQP-UHFFFAOYSA-N 3-nitrobicyclo[2.2.1]hept-5-ene-2,3-dicarboxylic acid Chemical compound C1C2C=CC1C(C(=O)O)C2(C(O)=O)[N+]([O-])=O QJZYHAIUNVAGQP-UHFFFAOYSA-N 0.000 description 1
- GWXXFGWOWOJEEX-UHFFFAOYSA-N 4,4,4-trihydroxy-1-phenylbutan-1-one Chemical compound OC(CCC(=O)C1=CC=CC=C1)(O)O GWXXFGWOWOJEEX-UHFFFAOYSA-N 0.000 description 1
- HBTAOSGHCXUEKI-UHFFFAOYSA-N 4-chloro-n,n-dimethyl-3-nitrobenzenesulfonamide Chemical compound CN(C)S(=O)(=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 HBTAOSGHCXUEKI-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- RETXUWFOZKDPPJ-UHFFFAOYSA-N 4-hydroxybutyl octanoate Chemical compound CCCCCCCC(=O)OCCCCO RETXUWFOZKDPPJ-UHFFFAOYSA-N 0.000 description 1
- IPNFHEWNDOORKH-UHFFFAOYSA-N 6-methylheptyl 2-hydroxybenzoate Chemical compound CC(C)CCCCCOC(=O)C1=CC=CC=C1O IPNFHEWNDOORKH-UHFFFAOYSA-N 0.000 description 1
- SJIDAAGFCNIAJP-UHFFFAOYSA-N 6-methylheptyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCC(C)C SJIDAAGFCNIAJP-UHFFFAOYSA-N 0.000 description 1
- XUVVLJKRLAXOKZ-UHFFFAOYSA-N 7-methyloctyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCC(C)C XUVVLJKRLAXOKZ-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 244000144927 Aloe barbadensis Species 0.000 description 1
- 235000002961 Aloe barbadensis Nutrition 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 108010085443 Anserine Proteins 0.000 description 1
- 241000256837 Apidae Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- XHVAWZZCDCWGBK-WYRLRVFGSA-M Aurothioglucose Chemical compound OC[C@H]1O[C@H](S[Au])[C@H](O)[C@@H](O)[C@@H]1O XHVAWZZCDCWGBK-WYRLRVFGSA-M 0.000 description 1
- GWZYPXHJIZCRAJ-UHFFFAOYSA-N Biliverdin Natural products CC1=C(C=C)C(=C/C2=NC(=Cc3[nH]c(C=C/4NC(=O)C(=C4C)C=C)c(C)c3CCC(=O)O)C(=C2C)CCC(=O)O)NC1=O GWZYPXHJIZCRAJ-UHFFFAOYSA-N 0.000 description 1
- RCNSAJSGRJSBKK-NSQVQWHSSA-N Biliverdin IX Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(\C=C/2C(=C(C)C(=C/C=3C(=C(C=C)C(=O)N=3)C)/N\2)CCC(O)=O)N1 RCNSAJSGRJSBKK-NSQVQWHSSA-N 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- 125000000739 C2-C30 alkenyl group Chemical group 0.000 description 1
- HBMZNWKFVFUGND-UHFFFAOYSA-N CC1(C)C(C2=O)(C)CCC1(S(O)(=O)=O)C2=CC1=CC=CC=C1 Chemical compound CC1(C)C(C2=O)(C)CCC1(S(O)(=O)=O)C2=CC1=CC=CC=C1 HBMZNWKFVFUGND-UHFFFAOYSA-N 0.000 description 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 108010087806 Carnosine Proteins 0.000 description 1
- 229910052684 Cerium Inorganic materials 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- LAAPRQODJPXAHC-UHFFFAOYSA-N Coniferyl benzoate Natural products C1=C(O)C(OC)=CC(C=CCOC(=O)C=2C=CC=CC=2)=C1 LAAPRQODJPXAHC-UHFFFAOYSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- IMROMDMJAWUWLK-UHFFFAOYSA-N Ethenol Chemical compound OC=C IMROMDMJAWUWLK-UHFFFAOYSA-N 0.000 description 1
- PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 206010019030 Hair colour changes Diseases 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- SLRNWACWRVGMKD-UHFFFAOYSA-N L-anserine Natural products CN1C=NC(CC(NC(=O)CCN)C(O)=O)=C1 SLRNWACWRVGMKD-UHFFFAOYSA-N 0.000 description 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-M L-ascorbate Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] CIWBSHSKHKDKBQ-JLAZNSOCSA-M 0.000 description 1
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 1
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- FFFHZYDWPBMWHY-VKHMYHEASA-N L-homocysteine Chemical compound OC(=O)[C@@H](N)CCS FFFHZYDWPBMWHY-VKHMYHEASA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 102000010445 Lactoferrin Human genes 0.000 description 1
- 108010063045 Lactoferrin Proteins 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 125000003047 N-acetyl group Chemical group 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- WYWZRNAHINYAEF-UHFFFAOYSA-N Padimate O Chemical compound CCCCC(CC)COC(=O)C1=CC=C(N(C)C)C=C1 WYWZRNAHINYAEF-UHFFFAOYSA-N 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920002367 Polyisobutene Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000210053 Potentilla elegans Species 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- KNAHARQHSZJURB-UHFFFAOYSA-N Propylthiouracile Chemical compound CCCC1=CC(=O)NC(=S)N1 KNAHARQHSZJURB-UHFFFAOYSA-N 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 235000004443 Ricinus communis Nutrition 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 1
- 244000044822 Simmondsia californica Species 0.000 description 1
- 235000004433 Simmondsia californica Nutrition 0.000 description 1
- BCKXLBQYZLBQEK-KVVVOXFISA-M Sodium oleate Chemical compound [Na+].CCCCCCCC\C=C/CCCCCCCC([O-])=O BCKXLBQYZLBQEK-KVVVOXFISA-M 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 102000002933 Thioredoxin Human genes 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- IHUMNXSBUOIDQI-UHFFFAOYSA-N Triethanolamine myristate Chemical compound OCCN(CCO)CCO.CCCCCCCCCCCCCC(O)=O IHUMNXSBUOIDQI-UHFFFAOYSA-N 0.000 description 1
- PHYFQTYBJUILEZ-UHFFFAOYSA-N Trioleoylglycerol Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC PHYFQTYBJUILEZ-UHFFFAOYSA-N 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 230000006750 UV protection Effects 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 1
- 241001135917 Vitellaria paradoxa Species 0.000 description 1
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 description 1
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 description 1
- HEAHZSUCFKFERC-IWGRKNQJSA-N [(2e)-2-[[4-[(e)-[7,7-dimethyl-3-oxo-4-(sulfomethyl)-2-bicyclo[2.2.1]heptanylidene]methyl]phenyl]methylidene]-7,7-dimethyl-3-oxo-4-bicyclo[2.2.1]heptanyl]methanesulfonic acid Chemical compound CC1(C)C2CCC1(CS(O)(=O)=O)C(=O)\C2=C\C(C=C1)=CC=C1\C=C/1C(=O)C2(CS(O)(=O)=O)CCC\1C2(C)C HEAHZSUCFKFERC-IWGRKNQJSA-N 0.000 description 1
- OEWBEINAQKIQLZ-CMRBMDBWSA-N [(2s)-2-[(2r)-3,4-bis(2-hexyldecanoyloxy)-5-oxo-2h-furan-2-yl]-2-(2-hexyldecanoyloxy)ethyl] 2-hexyldecanoate Chemical compound CCCCCCCCC(CCCCCC)C(=O)OC[C@H](OC(=O)C(CCCCCC)CCCCCCCC)[C@H]1OC(=O)C(OC(=O)C(CCCCCC)CCCCCCCC)=C1OC(=O)C(CCCCCC)CCCCCCCC OEWBEINAQKIQLZ-CMRBMDBWSA-N 0.000 description 1
- 239000002535 acidifier Substances 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910001854 alkali hydroxide Inorganic materials 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 125000005036 alkoxyphenyl group Chemical group 0.000 description 1
- 125000005250 alkyl acrylate group Chemical group 0.000 description 1
- 125000005210 alkyl ammonium group Chemical group 0.000 description 1
- 125000002877 alkyl aryl group Chemical group 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- 229940061720 alpha hydroxy acid Drugs 0.000 description 1
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 1
- 239000011795 alpha-carotene Substances 0.000 description 1
- 235000003903 alpha-carotene Nutrition 0.000 description 1
- ANVAOWXLWRTKGA-HLLMEWEMSA-N alpha-carotene Natural products C(=C\C=C\C=C(/C=C/C=C(\C=C\C=1C(C)(C)CCCC=1C)/C)\C)(\C=C\C=C(/C=C/[C@H]1C(C)=CCCC1(C)C)\C)/C ANVAOWXLWRTKGA-HLLMEWEMSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 150000004645 aluminates Chemical class 0.000 description 1
- 229940063655 aluminum stearate Drugs 0.000 description 1
- UBNYRXMKIIGMKK-RMKNXTFCSA-N amiloxate Chemical compound COC1=CC=C(\C=C\C(=O)OCCC(C)C)C=C1 UBNYRXMKIIGMKK-RMKNXTFCSA-N 0.000 description 1
- 229960002709 amiloxate Drugs 0.000 description 1
- CBTVGIZVANVGBH-UHFFFAOYSA-N aminomethyl propanol Chemical compound CC(C)(N)CO CBTVGIZVANVGBH-UHFFFAOYSA-N 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 239000012164 animal wax Substances 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- MYYIAHXIVFADCU-QMMMGPOBSA-N anserine Chemical compound CN1C=NC=C1C[C@H](NC(=O)CC[NH3+])C([O-])=O MYYIAHXIVFADCU-QMMMGPOBSA-N 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 235000010385 ascorbyl palmitate Nutrition 0.000 description 1
- 229940071097 ascorbyl phosphate Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 229960001799 aurothioglucose Drugs 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000002610 basifying agent Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229960001716 benzalkonium Drugs 0.000 description 1
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 1
- CYDRXTMLKJDRQH-UHFFFAOYSA-N benzododecinium Chemical compound CCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 CYDRXTMLKJDRQH-UHFFFAOYSA-N 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- 150000008366 benzophenones Chemical class 0.000 description 1
- 150000001565 benzotriazoles Chemical class 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- QBUVFDKTZJNUPP-UHFFFAOYSA-N biliverdin-IXalpha Natural products N1C(=O)C(C)=C(C=C)C1=CC1=C(C)C(CCC(O)=O)=C(C=C2C(=C(C)C(C=C3C(=C(C=C)C(=O)N3)C)=N2)CCC(O)=O)N1 QBUVFDKTZJNUPP-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- DODLBEDXTHPKOW-UHFFFAOYSA-N bis(2,3-dihydroxypropyl) butanedioate Chemical compound OCC(O)COC(=O)CCC(=O)OCC(O)CO DODLBEDXTHPKOW-UHFFFAOYSA-N 0.000 description 1
- WXNRYSGJLQFHBR-UHFFFAOYSA-N bis(2,4-dihydroxyphenyl)methanone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=C(O)C=C1O WXNRYSGJLQFHBR-UHFFFAOYSA-N 0.000 description 1
- DTVQVQGCVNNOSX-UHFFFAOYSA-N bis(2-ethylhexyl) 2-[(4-methoxyphenyl)methylidene]propanedioate Chemical class CCCCC(CC)COC(=O)C(C(=O)OCC(CC)CCCC)=CC1=CC=C(OC)C=C1 DTVQVQGCVNNOSX-UHFFFAOYSA-N 0.000 description 1
- SODJJEXAWOSSON-UHFFFAOYSA-N bis(2-hydroxy-4-methoxyphenyl)methanone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=C(OC)C=C1O SODJJEXAWOSSON-UHFFFAOYSA-N 0.000 description 1
- YEAYGXLRPMKZBP-KQGICBIGSA-N bis(2-hydroxyethyl)azanium;(e)-3-(4-methoxyphenyl)prop-2-enoate Chemical compound OCCNCCO.COC1=CC=C(\C=C\C(O)=O)C=C1 YEAYGXLRPMKZBP-KQGICBIGSA-N 0.000 description 1
- 239000002981 blocking agent Substances 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- ULBTUVJTXULMLP-UHFFFAOYSA-N butyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCC ULBTUVJTXULMLP-UHFFFAOYSA-N 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- CQOVPNPJLQNMDC-ZETCQYMHSA-N carnosine Chemical compound [NH3+]CCC(=O)N[C@H](C([O-])=O)CC1=CNC=N1 CQOVPNPJLQNMDC-ZETCQYMHSA-N 0.000 description 1
- 229940044199 carnosine Drugs 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- 150000001783 ceramides Chemical class 0.000 description 1
- ZMIGMASIKSOYAM-UHFFFAOYSA-N cerium Chemical compound [Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce] ZMIGMASIKSOYAM-UHFFFAOYSA-N 0.000 description 1
- 229940085262 cetyl dimethicone Drugs 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000007810 chemical reaction solvent Substances 0.000 description 1
- 239000003245 coal Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- LAAPRQODJPXAHC-AATRIKPKSA-N coniferyl benzoate Chemical compound C1=C(O)C(OC)=CC(\C=C\COC(=O)C=2C=CC=CC=2)=C1 LAAPRQODJPXAHC-AATRIKPKSA-N 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000000490 cosmetic additive Substances 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 125000001047 cyclobutenyl group Chemical group C1(=CCC1)* 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000002433 cyclopentenyl group Chemical group C1(=CCCC1)* 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000298 cyclopropenyl group Chemical group [H]C1=C([H])C1([H])* 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- OOTFVKOQINZBBF-UHFFFAOYSA-N cystamine Chemical compound CCSSCCN OOTFVKOQINZBBF-UHFFFAOYSA-N 0.000 description 1
- 229940099500 cystamine Drugs 0.000 description 1
- 229960002433 cysteine Drugs 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- GHVNFZFCNZKVNT-UHFFFAOYSA-M decanoate Chemical compound CCCCCCCCCC([O-])=O GHVNFZFCNZKVNT-UHFFFAOYSA-M 0.000 description 1
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- 229940031578 diisopropyl adipate Drugs 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- OUVIFZTVOXXNTJ-UHFFFAOYSA-L dipotassium dodecanoate Chemical compound C(CCCCCCCCCCC)(=O)[O-].C(CCCCCCCCCCC)(=O)[O-].[K+].[K+] OUVIFZTVOXXNTJ-UHFFFAOYSA-L 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- GLCJMPWWQKKJQZ-UHFFFAOYSA-L disodium;2-[4-(4,6-disulfonato-1h-benzimidazol-2-yl)phenyl]-1h-benzimidazole-4,6-disulfonate;hydron Chemical compound [Na+].[Na+].C1=C(S(O)(=O)=O)C=C2NC(C3=CC=C(C=C3)C3=NC4=C(C=C(C=C4N3)S(=O)(=O)O)S([O-])(=O)=O)=NC2=C1S([O-])(=O)=O GLCJMPWWQKKJQZ-UHFFFAOYSA-L 0.000 description 1
- PWWSSIYVTQUJQQ-UHFFFAOYSA-N distearyl thiodipropionate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)CCSCCC(=O)OCCCCCCCCCCCCCCCCCC PWWSSIYVTQUJQQ-UHFFFAOYSA-N 0.000 description 1
- MCPKSFINULVDNX-UHFFFAOYSA-N drometrizole Chemical compound CC1=CC=C(O)C(N2N=C3C=CC=CC3=N2)=C1 MCPKSFINULVDNX-UHFFFAOYSA-N 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 229960004697 enzacamene Drugs 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 229940052296 esters of benzoic acid for local anesthesia Drugs 0.000 description 1
- CIXGAOKBHFBBTP-UHFFFAOYSA-N ethenyl 2-[4-(diethylamino)-2-hydroxybenzoyl]benzoate Chemical compound OC1=CC(N(CC)CC)=CC=C1C(=O)C1=CC=CC=C1C(=O)OC=C CIXGAOKBHFBBTP-UHFFFAOYSA-N 0.000 description 1
- BMOAQMNPJSPXIU-UHFFFAOYSA-N ethyl 2-(3-fluoro-4-nitrophenyl)propanoate Chemical compound CCOC(=O)C(C)C1=CC=C([N+]([O-])=O)C(F)=C1 BMOAQMNPJSPXIU-UHFFFAOYSA-N 0.000 description 1
- IAJNXBNRYMEYAZ-UHFFFAOYSA-N ethyl 2-cyano-3,3-diphenylprop-2-enoate Chemical compound C=1C=CC=CC=1C(=C(C#N)C(=O)OCC)C1=CC=CC=C1 IAJNXBNRYMEYAZ-UHFFFAOYSA-N 0.000 description 1
- DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 1
- 210000004709 eyebrow Anatomy 0.000 description 1
- 210000000720 eyelash Anatomy 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000003818 flash chromatography Methods 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- 229940098330 gamma linoleic acid Drugs 0.000 description 1
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 description 1
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 125000003147 glycosyl group Chemical group 0.000 description 1
- 229940087559 grape seed Drugs 0.000 description 1
- 239000008169 grapeseed oil Substances 0.000 description 1
- 159000000011 group IA salts Chemical class 0.000 description 1
- 239000008266 hair spray Substances 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 1
- PMMXXYHTOMKOAZ-UHFFFAOYSA-N hexadecyl 7-methyloctanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCC(C)C PMMXXYHTOMKOAZ-UHFFFAOYSA-N 0.000 description 1
- HTDJPCNNEPUOOQ-UHFFFAOYSA-N hexamethylcyclotrisiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O1 HTDJPCNNEPUOOQ-UHFFFAOYSA-N 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 229960004881 homosalate Drugs 0.000 description 1
- 239000004021 humic acid Substances 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 150000002460 imidazoles Chemical class 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229940079865 intestinal antiinfectives imidazole derivative Drugs 0.000 description 1
- 229920000831 ionic polymer Polymers 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940089456 isopropyl stearate Drugs 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 1
- 229940078795 lactoferrin Drugs 0.000 description 1
- 235000021242 lactoferrin Nutrition 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 125000005647 linker group Chemical group 0.000 description 1
- 229960004232 linoleic acid Drugs 0.000 description 1
- AGBQKNBQESQNJD-UHFFFAOYSA-N lipoic acid Chemical compound OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000012184 mineral wax Substances 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 150000002780 morpholines Chemical class 0.000 description 1
- 229940105132 myristate Drugs 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 1
- 229960002446 octanoic acid Drugs 0.000 description 1
- 229960003921 octisalate Drugs 0.000 description 1
- 229960000601 octocrylene Drugs 0.000 description 1
- WCJLCOAEJIHPCW-UHFFFAOYSA-N octyl 2-hydroxybenzoate Chemical compound CCCCCCCCOC(=O)C1=CC=CC=C1O WCJLCOAEJIHPCW-UHFFFAOYSA-N 0.000 description 1
- FATBGEAMYMYZAF-KTKRTIGZSA-N oleamide Chemical compound CCCCCCCC\C=C/CCCCCCCC(N)=O FATBGEAMYMYZAF-KTKRTIGZSA-N 0.000 description 1
- 229940049964 oleate Drugs 0.000 description 1
- 229960002969 oleic acid Drugs 0.000 description 1
- 150000002888 oleic acid derivatives Chemical class 0.000 description 1
- BARWIPMJPCRCTP-UHFFFAOYSA-N oleic acid oleyl ester Natural products CCCCCCCCC=CCCCCCCCCOC(=O)CCCCCCCC=CCCCCCCCC BARWIPMJPCRCTP-UHFFFAOYSA-N 0.000 description 1
- FATBGEAMYMYZAF-UHFFFAOYSA-N oleicacidamide-heptaglycolether Natural products CCCCCCCCC=CCCCCCCCC(N)=O FATBGEAMYMYZAF-UHFFFAOYSA-N 0.000 description 1
- 150000002891 organic anions Chemical class 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- 229960001173 oxybenzone Drugs 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N palmitic acid group Chemical group C(CCCCCCCCCCCCCCC)(=O)O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- XCRBXWCUXJNEFX-UHFFFAOYSA-N peroxybenzoic acid Chemical class OOC(=O)C1=CC=CC=C1 XCRBXWCUXJNEFX-UHFFFAOYSA-N 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 150000003014 phosphoric acid esters Chemical class 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920003216 poly(methylphenylsiloxane) Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000223 polyglycerol Polymers 0.000 description 1
- 229940100498 polysilicone-15 Drugs 0.000 description 1
- 229910052573 porcelain Inorganic materials 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- JKANAVGODYYCQF-UHFFFAOYSA-N prop-2-yn-1-amine Chemical compound NCC#C JKANAVGODYYCQF-UHFFFAOYSA-N 0.000 description 1
- PZQSQRCNMZGWFT-QXMHVHEDSA-N propan-2-yl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC(C)C PZQSQRCNMZGWFT-QXMHVHEDSA-N 0.000 description 1
- ZPWFUIUNWDIYCJ-UHFFFAOYSA-N propan-2-yl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC(C)C ZPWFUIUNWDIYCJ-UHFFFAOYSA-N 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 229960002662 propylthiouracil Drugs 0.000 description 1
- 239000011241 protective layer Substances 0.000 description 1
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 229960000342 retinol acetate Drugs 0.000 description 1
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 1
- 235000019173 retinyl acetate Nutrition 0.000 description 1
- 239000011770 retinyl acetate Substances 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 229940066675 ricinoleate Drugs 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 150000003902 salicylic acid esters Chemical class 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 229940057910 shea butter Drugs 0.000 description 1
- 229910000077 silane Inorganic materials 0.000 description 1
- 150000004760 silicates Chemical class 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229940080279 sodium cocoate Drugs 0.000 description 1
- RYYKJJJTJZKILX-UHFFFAOYSA-M sodium octadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC([O-])=O RYYKJJJTJZKILX-UHFFFAOYSA-M 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 1
- YYGNTYWPHWGJRM-AAJYLUCBSA-N squalene Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CC\C=C(/C)CC\C=C(/C)CCC=C(C)C YYGNTYWPHWGJRM-AAJYLUCBSA-N 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 229940073743 steareth-20 methacrylate Drugs 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- ABTZKZVAJTXGNN-UHFFFAOYSA-N stearyl heptanoate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)CCCCCC ABTZKZVAJTXGNN-UHFFFAOYSA-N 0.000 description 1
- 229940098758 stearyl heptanoate Drugs 0.000 description 1
- 235000021286 stilbenes Nutrition 0.000 description 1
- 150000001629 stilbenes Chemical class 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- CXVGEDCSTKKODG-UHFFFAOYSA-N sulisobenzone Chemical compound C1=C(S(O)(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC=CC=C1 CXVGEDCSTKKODG-UHFFFAOYSA-N 0.000 description 1
- 229960000368 sulisobenzone Drugs 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- 150000003892 tartrate salts Chemical class 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- UWHCKJMYHZGTIT-UHFFFAOYSA-N tetraethylene glycol Chemical compound OCCOCCOCCOCCO UWHCKJMYHZGTIT-UHFFFAOYSA-N 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 238000011285 therapeutic regimen Methods 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- 229940094937 thioredoxin Drugs 0.000 description 1
- 108060008226 thioredoxin Proteins 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M trans-cinnamate Chemical class [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- LOIYMIARKYCTBW-OWOJBTEDSA-N trans-urocanic acid Chemical compound OC(=O)\C=C\C1=CNC=N1 LOIYMIARKYCTBW-OWOJBTEDSA-N 0.000 description 1
- LOIYMIARKYCTBW-UHFFFAOYSA-N trans-urocanic acid Natural products OC(=O)C=CC1=CNC=N1 LOIYMIARKYCTBW-UHFFFAOYSA-N 0.000 description 1
- 229910052723 transition metal Inorganic materials 0.000 description 1
- 150000003624 transition metals Chemical class 0.000 description 1
- 150000003918 triazines Chemical class 0.000 description 1
- 229940121343 tricaprilin Drugs 0.000 description 1
- 125000005591 trimellitate group Chemical group 0.000 description 1
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 1
- SJXYCCRUTIHMCE-GOXDOWKOSA-K tripotassium;(z)-12-hydroxyoctadec-9-enoate;propane-1,2,3-triol Chemical compound [K+].[K+].[K+].OCC(O)CO.CCCCCCC(O)C\C=C/CCCCCCCC([O-])=O.CCCCCCC(O)C\C=C/CCCCCCCC([O-])=O.CCCCCCC(O)C\C=C/CCCCCCCC([O-])=O SJXYCCRUTIHMCE-GOXDOWKOSA-K 0.000 description 1
- ZQTYRTSKQFQYPQ-UHFFFAOYSA-N trisiloxane Chemical compound [SiH3]O[SiH2]O[SiH3] ZQTYRTSKQFQYPQ-UHFFFAOYSA-N 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 229940040064 ubiquinol Drugs 0.000 description 1
- QNTNKSLOFHEFPK-UPTCCGCDSA-N ubiquinol-10 Chemical compound COC1=C(O)C(C)=C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)C(O)=C1OC QNTNKSLOFHEFPK-UPTCCGCDSA-N 0.000 description 1
- 229940035936 ubiquinone Drugs 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 229930195735 unsaturated hydrocarbon Natural products 0.000 description 1
- 239000012178 vegetable wax Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 239000011686 zinc sulphate Substances 0.000 description 1
- 235000009529 zinc sulphate Nutrition 0.000 description 1
- 229910052726 zirconium Inorganic materials 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/10—Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/896—Polysiloxanes containing atoms other than silicon, carbon, oxygen and hydrogen, e.g. dimethicone copolyol phosphate
- A61K8/898—Polysiloxanes containing atoms other than silicon, carbon, oxygen and hydrogen, e.g. dimethicone copolyol phosphate containing nitrogen, e.g. amodimethicone, trimethyl silyl amodimethicone or dimethicone propyl PG-betaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/58—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
- A61K8/585—Organosilicon compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8152—Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G77/00—Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
- C08G77/04—Polysiloxanes
- C08G77/38—Polysiloxanes modified by chemical after-treatment
- C08G77/382—Polysiloxanes modified by chemical after-treatment containing atoms other than carbon, hydrogen, oxygen or silicon
- C08G77/388—Polysiloxanes modified by chemical after-treatment containing atoms other than carbon, hydrogen, oxygen or silicon containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/57—Compounds covalently linked to a(n inert) carrier molecule, e.g. conjugates, pro-fragrances
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- General Chemical & Material Sciences (AREA)
- Cosmetics (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Silicon Polymers (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Abstract
Description
Derivados organosilícicos de amino hidroxibenzofenonas y su uso como filtros de los rayos UV-A en las preparaciones cosméticas.Organosilicon amino derivatives hydroxybenzophenones and their use as lightning filters UV-A in cosmetic preparations.
La presente invención se refiere a los derivados organosilícicos de amino hidroxibenzofenonas, a un proceso para su preparación, a las composiciones que comprenden estos derivados y al uso de los mismos.The present invention relates to derivatives Organosilicic amino hydroxybenzophenones, to a process for its preparation, to the compositions comprising these derivatives and to use of them.
Las EP-A-1046391, EP-A-1133980 y WO-A-0172935 divulgan hidroxibenzofenonas sustituidas con amino como agentes bloqueadores de los rayos UVA, EP-A-1046391, EP-A-1133980 como filtros de rayos UV foto-estables en preparaciones farmacéuticas y cosméticas y WO-A-0172935 para uso en textiles.The EP-A-1046391, EP-A-1133980 and WO-A-0172935 disclose amino substituted hydroxybenzophenones as blocking agents of UVA rays, EP-A-1046391, EP-A-1133980 as lightning filters Photo-stable UV in pharmaceutical preparations and Cosmetics and WO-A-0172935 for use in textiles
Los compuestos organosilícicos que tienen sustituyentes de hidroxibenzofenonas los cuales actúan como constituyentes de bloqueo solar son divulgados en US-A-6114561, EP-A-0478284, EP-A-0712855, EP-A-0982310, US-A-5270426, FR-A-2684551 y GB-A-1167759.The organosilicon compounds that have hydroxybenzophenone substituents which act as sun block constituents are disclosed in US-A-6114561, EP-A-0478284, EP-A-0712855, EP-A-0982310, US-A-5270426, FR-A-2684551 and GB-A-1167759.
Sin embargo, ningún documento del arte anterior citado previamente divulga derivados organosilícicos de las amino hidroxibenzofenonas.However, no prior art document previously cited discloses organosilicon derivatives of amino hydroxybenzophenones.
Más particularmente, la invención se refiere a los compuestos organosilícicos que comprenden una unidad de la fórmula IMore particularly, the invention relates to organosilicon compounds comprising a unit of the formula I
dondewhere
a es de 0, 1 ó 2,a is 0, 1 or 2,
R^{1} es hidrógeno, un grupo hidrocarburo C_{1}-C_{30} saturado o no saturado o un grupo trimetilsililoxi; yR1 is hydrogen, a hydrocarbon group C_ {1} -C_ {30} saturated or unsaturated or a group trimethylsilyloxy; Y
Z es una hidroxibenzofenona sustituida con amino de la fórmula IIIZ is an amino substituted hydroxybenzophenone of formula III
donde R^{3} y R^{4} son
independientemente hidrógeno,
C_{1}-C_{20}alquil,
C_{2}-C_{20}alquenil,
C_{3}-C_{10}ciclo-
alquil o
C_{3}-C_{10}cicloalquenil o R^{3} y R^{4},
junto con el átomo de nitrógeno al que están unidos, forman un
anillo de 5 a 6
miembros;where R 3 and R 4 are independently hydrogen, C 1 -C 20 alkyl, C 2 -C 20 alkenyl, C 3 -C 10 cycle-
alkyl or C 3 -C 10 cycloalkenyl or R 3 and R 4, together with the nitrogen atom to which they are attached, form a 5- to 6-membered ring;
X es -O- o -NR^{5}- donde R^{5} es hidrógeno, C_{1}-C_{20}alquil, C_{2}-C_{2}Oalquenil, C_{3}-C_{10}cicloalquil o C_{3}-C_{10}cicloalquenil; yX is -O- or -NR 5 - where R 5 is hydrogen, C 1 -C 20 alkyl, C 2 -C 2 Oalquenil, C 3 -C 10 cycloalkyl or C 3 -C 10 cycloalkenyl; Y
Y es una cadena alquenileno o C_{3}-C_{12}alquileno divalente;And it is an alkenylene chain or C 3 -C 12 divalent alkylene;
y, opcionalmente, una unidad de la fórmula IIand, optionally, a unit of the formula II
dondewhere
b es de 0, 1, 2, 3; yb is 0, 1, 2, 3; Y
R^{2} es hidrógeno, un grupo hidrocarburo C_{1}-C_{30} saturado o no saturado o un grupo trimetilsililoxi.R2 is hydrogen, a hydrocarbon group C_ {1} -C_ {30} saturated or unsaturated or a group trimethylsilyloxy.
Los compuestos organosilícicos adecuados son materiales poliméricos que pueden ser homopolímeros que consisten solamente en unidades de la fórmula I, o pueden ser copolímeros que contienen las dos unidades que tienen la fórmula general I ó II. Las unidades de la fórmula I pueden ser distribuidas de manera aleatoria en un polímero de organosiloxano, estas pueden ser las unidades de bloqueo finales del polímero o pueden estar localizadas al final del polímero, y pendientes en una cadena de polímero, al mismo tiempo. Los compuestos organosilícicos pueden variar desde líquidos que fluyen libremente a sólidos resinosos o materiales del tipo goma, altamente viscosos.Suitable organosilicon compounds are polymeric materials that can be homopolymers that consist only in units of the formula I, or they can be copolymers that they contain the two units that have the general formula I or II. The units of formula I can be distributed in a manner randomized in an organosiloxane polymer, these may be the final polymer blocking units or may be located at the end of the polymer, and earrings in a polymer chain, at Same time. Organosilicon compounds may vary from liquids that flow freely to resinous solids or materials of the rubber type, highly viscous.
Si a es 2 los dos sustituyentes R^{1} pueden ser idénticos o diferentes. Si b es 2 ó 3, los dos o tres sustituyentes R^{2} pueden ser idénticos o diferentes. Si el polímero contiene más de una unidad de la fórmula I, los sustituyentes R^{1} pueden ser idénticos o diferentes de una unidad a otra. Si el polímero contiene más de una unidad de la fórmula II, los sustituyentes R^{2} pueden ser idénticos o diferentes de una unidad a otra.If a is 2 the two substituents R1 can Be identical or different. If b is 2 or 3, both two or three R2 substituents may be identical or different. If he polymer contains more than one unit of the formula I, the R 1 substituents may be identical or different from one drive to another. If the polymer contains more than one unit of the formula II, the R2 substituents may be identical or different from one unit to another.
Los ejemplos de un grupo hidrocarburo C_{1}-C_{30} saturado o no saturado incluyen C_{1}-C_{30}alquil tales como metil, etil, propil y butil; C_{2}-C_{30}alquenil tales como vinil y alil; y aril sustituido o no sustituido como fenil, alcaril y alcoxifenil. El grupo hidrocarburo es sustituido o no sustituido por ejemplo, halógeno, por ejemplo, el grupo hidrocarburo C_{1}-C_{18} halogenado.Examples of a hydrocarbon group C 1 -C 30 saturated or unsaturated include C 1 -C 30 alkyl such as methyl, ethyl, propyl and butyl; C 2 -C 30 alkenyl such as vinyl and alil; and substituted or unsubstituted aryl such as phenyl, alkaryl and alkoxyphenyl. The hydrocarbon group is substituted or unsubstituted for example, halogen, for example, the hydrocarbon group C 1 -C 18 halogenated.
El alquil y el alquenil pueden ser de cadena lineal o ramificada, por ejemplo, metil, etil, 3-propil, 2-propil, 2-metil-3-propil, 3-butil, 4-butil, 4-pentil, 5-pentil, 6-hexil, 2-propen-2-il, 2-propen-3-il, 3-buten-3-il, 3-buten-4-il, 4-penten-4-il, 4-penten-5-il, (3-metil)-penta-2,4- dien-4 ó 5-il, 11-dodecen-11-il.The alkyl and alkenyl can be chain linear or branched, for example, methyl, ethyl, 3-propyl, 2-propyl, 2-methyl-3-propyl, 3-butyl, 4-butyl, 4-pentil, 5-pentil, 6-hex, 2-propen-2-il, 2-propen-3-il, 3-buten-3-il, 3-buten-4-il, 4-penten-4-il, 4-penten-5-il, (3-methyl) -penta-2,4- dien-4 or 5-il, 11-dodecen-11-il.
Los ejemplos de cicloalquil y cicloalquenil incluyen ciclopropil, 2-metil-ciclopropil, ciclobutil, ciclopentil, ciclohexil, ciclopropenil, ciclobutenil, ciclopentenil, (3-metil)-ciclopenta-2,4-dienil y 11-ciclododecenil.Examples of cycloalkyl and cycloalkenyl include cyclopropyl, 2-methyl-cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cyclopropenyl, cyclobutenyl, cyclopentenyl, (3-methyl) -cyclopenta-2,4-dienyl and 11-cyclododecenyl.
Los términos "cadena C_{3}-C_{l2}alquileno divalente" y "cadena C_{3}-C_{l2}alquenileno divalente" significan grupos de enlace, en particular, los grupos de enlace que unen el residuo cromóforo que absorbe la radiación UV a la mitad silano, oligosiloxano o polisiloxano. Los ejemplos de C_{3}-C_{l2}alquileno incluyen los residuos de hidrocarburos saturados de cadena lineal o ramificada tales como el 3-propileno, 2-propileno, 2-metil-3-propileno, 3-butileno, 4-butileno, 4-pentileno, 5-pentileno, 6-hexileno, y similares. Los ejemplos de C_{3}-C_{l2}alquenileno incluyen los residuos de hidrocarburos no saturados que contienen al menos un enlace doble, tales como por ejemplo, 2-propen-2-ileno, 2-propen-3-ileno, 3-buten-3-ileno, 3-buten-4-ileno, 4-penten-4-ileno, 4-penten-5-ileno, (3-metil)-penta-2,4-dien-4 ó 5-ileno, 11-dodecen-11-ileno, y similares. Las cadenas de alquileno o alquenileno divalentes pueden ser interrumpidas por uno o varios átomos de oxígeno. Los ejemplos de grupos de enlace interrumpidos por oxígeno son por ejemplo 2-etiloxi-et-2-ileno, 4-butiloxi-et-2-ileno ó 3,6-dioxa-8-octilen. Enlazadores particularmente preferidos son -CH=CH-(CH_{2})_{n}-, -C(CH_{2})-(CH_{2})_{n}-, -CH_{2}-CH_{2}-(CH_{2})_{n}- y -CH (CH_{3})-(CH_{2})_{n}- donde n es un número entero de 0 a 10.The terms "string C 3 -C_ {l2} divalent alkylene "and" chain C 3 -C_ {l2} divalent alkenylene " mean link groups, in particular, the link groups that bind the chromophore residue that absorbs UV radiation in half silane, oligosiloxane or polysiloxane. The examples of C 3 -C l 2 alkylene include residues of saturated straight or branched chain hydrocarbons such as the 3-propylene, 2-propylene, 2-methyl-3-propylene, 3-butylene, 4-butylene, 4-pentylene, 5-pentylene, 6-hexylene, and the like. The examples of C 3 -C_ {l2} alkenylene include residues of unsaturated hydrocarbons containing at least one double bond, such as for example 2-propen-2-ileum, 2-propen-3-ileum, 3-buten-3-ileum, 3-buten-4-ileum, 4-penten-4-ileum, 4-penten-5-ileum, (3-methyl) -penta-2,4-dien-4 or 5-ileum, 11-dodecen-11-ileum, and the like Divalent alkylene or alkenylene chains They can be interrupted by one or several oxygen atoms. The examples of oxygen interrupted linkage groups are by example 2-ethyloxy-et-2-ylene, 4-butyloxy-et-2-ylene or 3,6-dioxa-8-octylene. Particularly preferred linkers are -CH = CH- (CH2) n -, -C (CH 2) - (CH 2) n -, -CH 2 -CH 2 - (CH 2) n - and -CH (CH 3) - (CH 2) n - where n is an integer of 0 to 10.
En los compuestos organosilícicos de la invención las siguientes preferencias se aplicarán de forma independiente, colectiva o en cualquier combinación o sub-combinación:In the organosilicon compounds of the invention the following preferences will be applied in a way independent, collective or in any combination or sub-combination:
(a) compuestos organosilícicos en los que el número de unidades de la fórmula I se limita a un máximo de 50%, más preferiblemente de 10 a 40%, lo más preferiblemente de 30 a 40% del número total de unidades de siloxano en la molécula;(a) organosilicon compounds in which the number of units of formula I is limited to a maximum of 50%, more preferably from 10 to 40%, most preferably from 30 to 40% of the total number of siloxane units in the molecule;
(b) homopolímeros y copolímeros de organosiloxano sustancialmente lineales líquidos, por ejemplo los que tienen una viscosidad desde 50-20000 m^{2}/s;(b) homopolymers and copolymers of liquid substantially linear organosiloxane, for example the which have a viscosity from 50-20000 m 2 / s;
(c) compuestos organosilícicos donde en las unidades de la fórmula I los significados siguientes se aplican de forma independiente, colectiva o en cualquier combinación o sub-combinación:(c) organosilicon compounds where in the units of formula I the following meanings apply from independently, collectively or in any combination or sub-combination:
- (C1)(C1)
- a es 1;to is 1;
- (C2)(C2)
- R^{1} es metil en 80%, preferiblemente 100% de unidades de la fórmula I;R1 is 80% methyl, preferably 100% units of the formula I;
- (C3)(C3)
- Y es 2-propileno, 3-propileno, 2-propen-2-ileno, 2-propen-3-ileno, 4-butileno ó 3-buten-4-ileno, preferiblemente 2-propen-2-ileno ó 2-propen-3-ileno;Y it's 2-propylene, 3-propylene, 2-propen-2-ileum, 2-propen-3-ileum, 4-butylene or 3-buten-4-ileum, preferably 2-propen-2-ileum or 2-propen-3-ileum;
- (C4)(C4)
- X es -0-;X is -0-;
- (C5)(C5)
- R^{3} y R^{4} son etil,R 3 and R 4 are ethyl,
(d) compuestos organosilícicos donde en las unidades de la fórmula II, los siguientes significados se aplican de forma independiente, colectiva o en cualquier combinación o sub- combinación:(d) organosilicon compounds where in the units of formula II, the following meanings apply independently, collectively or in any combination or sub- combination:
- (d1)(d1)
- preferiblemente al menos dos unidades de la fórmula II están presentes;preferably at least two units of formula II are present;
- (d2)(d2)
- b es 2;b is 2;
- (d3)(d3)
- R^{2} es metil en 80%, preferiblemente 100% de unidades de la fórmula II.R2 is 80% methyl, preferably 100% units of the formula II.
Cuando a = 1 y b = 2 el compuesto organosilícico es un polímero de diorgano-siloxano sustancialmente lineal o cíclico. Sin embargo, si el diorgano-siloxano es un polímero sustancialmente lineal al menos dos unidades de bloque final deben estar presentes, requiriendo así ya sea la presencia de dos unidades en las que a tiene un valor de 2 ó dos unidades en las que b es 3.When a = 1 and b = 2 the organosilicon compound it is a diorgano-siloxane polymer substantially linear or cyclic. However, if the Diorgano-siloxane is a substantially polymer linear at least two final block units must be present, thus requiring either the presence of two units in which to It has a value of 2 or two units in which b is 3.
Un polímero de diorgano-siloxano lineal preferido (en lo sucesivo: COMPUESTO) es un polímero compuesto por una unidad estructural de la fórmula IVa y una unidad estructural de la fórmula IVbA diorgano-siloxane polymer Linear Preferred (hereinafter: COMPOUND) is a polymer composed of a structural unit of formula IVa and a unit structural formula IVb
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
s unidades de la fórmula IVcs units of the formula IVc
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
y r unidades de fórmula IVdand r units of formula IVd
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
dondewhere
Z es tal como se definió anteriormente;Z is as defined above;
R^{1}, R^{6}, R^{7}, R^{8}, R^{9}, R^{10} y R^{11} independiente son como se definió anteriormente para R^{2};R 1, R 6, R 7, R 8, R 9, R 10 and R 11 independent are as defined above for R2;
B y B' independientemente son un grupo Z o un grupo R^{2};B and B 'independently are a group Z or a R2 group;
r es un número entero desde 0 a 200; yr is an integer from 0 to 200; Y
s es un número entero desde 0 a 50, en el que, al menos B o B' es Z cuando s es 0.s is an integer from 0 to 50, in which, at least B or B 'is Z when s is 0.
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
Los compuestos de la invención pueden ser preparados por hidrosililación de un compuesto organosilícico en el que cada unidad de la fórmula I es reemplazada por una unidad que tiene la fórmula VI (en lo sucesivo: derivados SiH).The compounds of the invention can be prepared by hydrosilylation of an organosilicon compound in the that each unit of formula I is replaced by a unit that It has the formula VI (hereinafter: SiH derivatives).
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
Los derivados SiH son bien conocidos en la industria de la silicona y están disponibles comercialmente. Se describen, por ejemplo, en las siguientes patentes: US 3,220,972, US 3,697,474 y US 4,340,709.SiH derivatives are well known in the silicone industry and are commercially available. Be described, for example, in the following patents: US 3,220,972, US 3,697,474 and US 4,340,709.
\newpage\ newpage
La hidrosililación puede ser llevada a cabo mediante la reacción del derivado SiH en presencia de un catalizador de metal de transición, por ejemplo, platino sobre carbón de piedra o un catalizador complejo de platino, como por ejemplo, el complejo de platino divinil-tetrametil disiloxano con un compuesto de la fórmula VIIHydrosilylation can be carried out by reacting the SiH derivative in the presence of a catalyst transition metal, for example, platinum on stone coal or a platinum complex catalyst, such as the complex of platinum divinyl tetramethyl disiloxane with a compound of formula VII
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
en la que R^{3}, R^{4} y X son como se definió para la fórmula III y Y' tiene la misma definición que Y en la fórmula III, pero es terminado bien con un doble o un triple enlace. La adición puede proceder en ambas posiciones del enlace carbono-carbono no saturado, lo que conduce a las mezclas isoméricas de los productos organosilícicos por ejemplo conteniendo dobles enlaces exo y endo.wherein R 3, R 4 and X are as defined for formula III and Y 'has the same definition that And in formula III, but it is finished well with a double or a triple bond The addition can proceed in both positions of the unsaturated carbon-carbon bond, which leads to isomeric mixtures of organosilicon products for example containing double exo links and endo.
La hidrosililación puede ser realizada en un solvente de reacción apropiado, por ejemplo, en isopropanol o tolueno. Los reactivos pueden estar presentes en cantidades molares aproximadamente iguales. La reacción puede ser ejecutada a una temperatura elevada, por ejemplo, en un rango desde 40ºC a 150ºC, preferiblemente desde 60ºC a 100ºC, por ejemplo, a alrededor de 80ºC.Hydrosilylation can be performed in a appropriate reaction solvent, for example, in isopropanol or Toluene. Reagents may be present in molar amounts. approximately equal. The reaction can be executed at a high temperature, for example, in a range from 40 ° C to 150 ° C, preferably from 60 ° C to 100 ° C, for example, at about 80 ° C
Los compuestos de la fórmula VII son generalmente conocidos y pueden ser preparados, por ejemplo, de acuerdo con el procedimiento descrito en EP 1,046,391 por acilación de los fenoles sustituidos con amino correspondientes seguido por la reacción con el alcohol o la amina respectivos tales como propinol, alcohol alílico, alcohol vinílico, prop-2-inil amina o vinil amina. Las amino hidroxibenzofenonas ejemplares que son particularmente adecuadas para la preparación de los compuestos de la invención incluyen el prop-2-inil éster del ácido 2-(4-dietilamino-2-hidroxibenzoil) benzoico, alil éster del ácido 2-(4-dietilamino-2-hidroxibenzoil) benzoico, vinil éster del ácido 2-(4-dietilamino-2-hidroxibenzoil) benzoico y N-prop-2-inil benzamida del ácido 2-(4-dietilamino-2-hidroxibenzoil) benzoico.The compounds of formula VII are generally known and can be prepared, for example, from according to the procedure described in EP 1,046,391 by acylation of the corresponding amino substituted phenols followed by the reaction with the respective alcohol or amine such as propinol, allyl alcohol, vinyl alcohol, prop-2-inyl amine or vinyl amine. The Exemplary amino hydroxybenzophenones that are particularly suitable for the preparation of the compounds of the invention include the prop-2-inyl ester of acid 2- (4-diethylamino-2-hydroxybenzoyl) benzoic acid allyl ester 2- (4-diethylamino-2-hydroxybenzoyl) benzoic acid vinyl ester 2- (4-diethylamino-2-hydroxybenzoyl) benzoic and N-prop-2-inil acid benzamide 2- (4-diethylamino-2-hydroxybenzoyl) benzoic.
Los compuestos de la presente invención tienen máximos de absorción en la región de los rayos UV-A y son efectivos en la absorción de la radiación ultravioleta en el rango de los rayos UV-A (320-400 nm), lo cual los hace particularmente adecuados para su uso en preparaciones cosméticas de protección solar donde la absorción en el rango de rayos UV-A es especialmente deseable.The compounds of the present invention have absorption maximums in the UV-A region and are effective in absorbing ultraviolet radiation in the UV-A range (320-400 nm), which makes them particularly suitable for use in cosmetic sunscreen preparations where absorption in UV-A range is especially desirable.
Así, la presente invención se refiere también a las composiciones que comprenden los nuevos compuestos organosilícicos, formulados en un soporte o sustrato adecuado. Normalmente, las composiciones de la invención son adoptadas para la protección de un material que es sensible a la radiación ultravioleta, en particular la radiación solar, como la piel y/o el pelo y comprende una cantidad foto-protectora efectiva de un compuesto organosilícico de la invención.Thus, the present invention also relates to the compositions comprising the new compounds organosilicon, formulated in a suitable support or substrate. Normally, the compositions of the invention are adopted to the protection of a material that is sensitive to radiation ultraviolet, in particular solar radiation, such as the skin and / or the hair and comprises a photo-protective amount Effective of an organosilicon compound of the invention.
Para la preparación de los agentes de protección contra la luz, especialmente de preparaciones para uso cosmético y/o dermatológico, tales como las formulaciones de protección solar y de protección de la piel para los productos cosméticos de todos los días, un compuesto de la presente invención puede ser incorporado en los agentes auxiliares, por ejemplo, una base cosmética, que se usa convencionalmente para estas formulaciones. Cuando sea conveniente, otros agentes de protección contra los rayos UV-A y/o UV-B convencionales también pueden ser añadidos. La combinación de filtros de rayos UV puede mostrar un efecto sinérgico. La preparación de dichos agentes de protección contra la luz es bien conocida por la persona experta en este campo. La concentración de los filtros de rayos UV no es crítica. Por ejemplo, la cantidad de los compuestos de la presente invención y opcionalmente un agente de protección contra los rayos UV-A o UV-B hidrofílico y/o lipofílico adicional distinto de los compuestos descritos en esta invención puede estar en el rango de desde 0.5 a 12% en peso de la composición total. Estos agentes de protección adicionales son ventajosamente seleccionados de los compuestos mencionados a continuación, sin que esto sea limitativo:For the preparation of protective agents against the light, especially preparations for cosmetic use and / or dermatological, such as sunscreen formulations and skin protection for all cosmetic products On days, a compound of the present invention can be incorporated into auxiliary agents, for example, a base cosmetic, which is conventionally used for these formulations. When appropriate, other protection agents against conventional UV-A and / or UV-B rays They can also be added. The combination of UV filters It can show a synergistic effect. The preparation of said agents Lightning protection is well known by the skilled person in this field. The concentration of UV filters is not review. For example, the amount of the compounds herein invention and optionally a lightning protection agent UV-A or UV-B hydrophilic and / or additional lipophilic other than the compounds described in this invention may be in the range of from 0.5 to 12% by weight of the total composition These additional protection agents are advantageously selected from the compounds mentioned to Then, without this being limiting:
Los ejemplos de agentes de protección contra los rayos UV-B, es decir, las sustancias que tienen los máximos de absorción entre alrededor de 290 y 320 nm, que entran en consideración para su combinación con los compuestos de la presente invención son, por ejemplo, los siguientes compuestos orgánicos e inorgánicos: acrilatos tales como 2-etilhexil 2-ciano-3,3-difenilacrilato (octocrileno, PARSOL® 340), etil-2-ciano-3,3-difenilacrilato y similares; derivados de alcanfor como 4-metil-bencilideno alcanfor (PARSOL® 5000), 3-bencilideno alcanfor, metosulfato de benzalconio alcanfor, poliacrilamidometil bencilideno alcanfor, sulfobencilideno alcanfor, sulfometil bencilideno alcanfor, ácido tereftalideno dialcanfor sulfónico y similares; derivados de cinamato como metoxicinamato de octilo (PARSOL® MCX), etoxietil metoxicinamato, dietanolamina metoxicinamato (PARSOL® Hydro), isoamil metoxicinamato y similares, así como los derivados del ácido cinámico unidos a los siloxanos; derivados del ácido p-aminobenzoico, como el ácido p-aminobenzoico, 2-etilhexil p-dimetilaminobenzoato, etil p-aminobenzoato N-oxipropilenatado, gliceril p-amino-benzoato; benzofenonas como benzofenona-3, benzofenona-4, 2,2', 4,4'-tetra-hidroxi-benzofenona, 2,2'-dihidroxi-4,4'-dimetoxibenzofenona y similares; ésteres del ácido benzalmalónico como di (2-etilhexil) 4-metoxibenzalmalonato; ésteres del ácido 2-(4-etoxi anilinometileno) propanodioico tal como el dietil éster del ácido 2-(4-etoxi anilinometileno)propanodioico tal como se describe en EP 895,776; compuestos de organosiloxano que contienen grupos benzmalonato como se describe en EP 358,584, EP 538,431 y EP 709,080; drometrizol trisiloxano (MEXORYL XL); pigmentos como TiO_{2} microparticulados, y similares, donde el término "microparticulado" se refiere a un tamaño de partícula desde alrededor de 5 nm a alrededor de 200 nm, en particular, desde alrededor de 15 nm a alrededor de 100 nm, y las partículas de TiO_{2} pueden ser recubiertas por óxidos de metal como, por ejemplo, óxidos de aluminio o circonio o por recubrimientos orgánicos, tales como, por ejemplo, polioles, meticona, estearato de aluminio, alquil silano; derivados de imidazol como, por ejemplo, ácido 2-fenil bencimidazol sulfónico y sus sales (PARSOL® HS). Las sales del ácido 2-fenil bencimidazol sulfónico son por ejemplo sales alcalinas, como las sales de sodio o potasio, sales de amonio, sales de morfolina, sales de aminas primarias, sec. y terc. como sales de monoetanolamina, dietanolamina y similares, derivados de salicilato como salicilato de iso-propilbencil, salicilato de bencil, salicilato de butil, salicilato de octil (NEO HELIOPAN OS), salicilato de isooctil o salicilato de homomentil (homosalato, HELIOPAN) y similares; derivados de triazina como octil triazona (UVINUL T-150), dioctil butamido triazona (UVASORB HEB), bis etoxifenol metoxifenil triazina (TINOSORB S) y similares; un polisiloxano que contiene un cromóforo UV-B como por ejemplo Polisilicona 15 (Dimeticodietil-benzalmalonato o Parsol SLX).Examples of protection agents against UV-B rays, that is, the substances that have the absorption maximums between about 290 and 320 nm, which enter consideration for its combination with the compounds herein invention are, for example, the following organic compounds and inorganic: acrylates such as 2-ethylhexyl 2-cyano-3,3-diphenylacrylate (octocrylene, PARSOL® 340), ethyl-2-cyano-3,3-diphenylacrylate and the like; camphor derivatives as 4-methyl-benzylidene camphor (PARSOL® 5000), 3-Benzylidene Camphor, Metosulfate benzalkonium camphor, polyacrylamidomethyl benzylidene camphor, sulfobenzylidene camphor, sulfomethyl benzylidene camphor, acid dialcane sulfonic terephthalidene and the like; derivatives of cinnamate as octyl methoxycinnamate (PARSOL® MCX), ethoxyethyl methoxycinnamate, diethanolamine methoxycinnamate (PARSOL® Hydro), isoamyl methoxycinnamate and the like, as well as acid derivatives cinnamic attached to siloxanes; acid derivatives p-aminobenzoic acid, such as acid p-aminobenzoic acid, 2-ethylhexyl p-dimethylaminobenzoate, ethyl p-aminobenzoate N-oxypropylene state, glyceryl p-amino benzoate; benzophenones such as benzophenone-3, benzophenone-4, 2,2 ', 4,4'-tetra-hydroxy-benzophenone, 2,2'-dihydroxy-4,4'-dimethoxybenzophenone and the like; esters of benzalmalonic acid as di (2-ethylhexyl) 4-methoxybenzalmalonate; acid esters 2- (4-ethoxy anilinomethylene) propanedioic such as the diethyl ester of 2- (4-ethoxy acid) anilinomethylene) propanedioic as described in EP 895,776; organosiloxane compounds containing groups benzmalonate as described in EP 358,584, EP 538,431 and EP 709,080; drometrizol trisiloxane (MEXORYL XL); pigments like TiO2 microparticulates, and the like, where the term "microparticulate" refers to a particle size from around 5 nm to about 200 nm, in particular from around 15 nm to about 100 nm, and the particles of TiO2 can be coated by metal oxides such as, by example, aluminum or zirconium oxides or coatings organic, such as, for example, polyols, methicone, stearate aluminum, alkyl silane; imidazole derivatives, such as 2-phenyl benzimidazole sulfonic acid and its salts (PARSOL® HS). The salts of 2-phenyl acid Sulfonic benzimidazole are for example alkaline salts, such as sodium or potassium salts, ammonium salts, morpholine salts, salts of primary amines, sec. and third. how do you get out of monoethanolamine, diethanolamine and the like, salicylate derivatives as iso-propylbenzyl salicylate, salicylate benzyl, butyl salicylate, octyl salicylate (NEO HELIOPAN OS), isooctyl salicylate or homomentile salicylate (homosalate, HELIOPAN) and the like; triazine derivatives such as octyl triazone (UVINUL T-150), dioctyl butamido triazone (UVASORB HEB), bis ethoxyphenol methoxyphenyl triazine (TINOSORB S) and the like; a polysiloxane containing a UV-B chromophore as for example Polysilicone 15 (Dimethicodiethyl-benzalmalonate or Parsol SLX).
Los ejemplos de agentes de protección contra los rayos UV-A es decir, las sustancias que tienen máximos de absorción entre alrededor de 320 y 400 nm, que entran en consideración para su combinación con los compuestos de la presente invención son, por ejemplo, los siguientes compuestos orgánicos e inorgánicos: derivados de dibenzoilmetano como el 4-tert. butil-4'-metoxidibenzoil-metano (PARASOL® 1789), dimetoxidibenzoilmetano, isopropildibenzoilmetano y similares; derivados de benzotriazol como 2,2'-metilen-bis-(6-(2H-benzotriazol-2-il)-4-(1,1,3,3,-tetrametilbutil)-fenol (TINOSORB M) y similares; ácidos fenileno-1,4-bis-bencimidazol sulfónicos o sales como el ácido 2,2-(1,4-fenileno) bis-(1H-bencimidazol-4,6-disulfónico) (NEOHELIOPAN AP); hidroxibenzofenonas amino sustituidas como el hexiléster del ácido 2-(4-dietilamino-2-hidroxi-benzoil)-benzoico como se describe en EP 1,046,391; pigmentos como ZnO microparticulado y similares, donde el término "microparticulado" se refiere a un tamaño de partículas desde alrededor de 5 nm a alrededor de 200 nm, en particular, desde alrededor de 15 nm a alrededor de 100 nm, y las partículas de ZnO pueden estar recubiertas por óxidos de metal como, por ejemplo, óxidos de aluminio o de circonio o por recubrimientos orgánicos, como por ejemplo, polioles, meticona, estearato de aluminio, alquil silano.Examples of protection agents against UV-A rays i.e. substances that have absorption maximums between about 320 and 400 nm, which enter consideration for its combination with the compounds herein invention are, for example, the following organic compounds and inorganic: dibenzoylmethane derivatives such as 4-tert. butyl-4'-methoxy dibenzoyl methane (PARASOL® 1789), dimethoxydibenzoylmethane, isopropyldibenzoylmethane and the like; benzotriazole derivatives as 2,2'-methylene-bis- (6- (2H-benzotriazol-2-yl) -4- (1,1,3,3, -tetramethylbutyl) -phenol (TINOSORB M) and the like; acids phenylene-1,4-bis-benzimidazole sulfonic acids or salts such as 2,2- (1,4-phenylene) acid bis- (1 H -benzimidazol-4,6-disulfonic acid) (NEOHELIOPAN AP); amino substituted hydroxybenzophenones such as the acid hexyl ester 2- (4-diethylamino-2-hydroxy-benzoyl) -benzoic acid as described in EP 1,046,391; pigments like ZnO microparticulate and the like where the term "microparticulate" refers to a particle size from around 5 nm to about 200 nm, in particular from around 15 nm to about 100 nm, and the ZnO particles they can be coated by metal oxides such as aluminum or zirconium oxides or organic coatings, such as polyols, methicone, aluminum stearate, alkyl silane
Como los derivados de dibenzoilmetano tienen foto-estabilidad limitada puede ser deseable foto-estabilizar estos agentes de protección contra los rayos UV-A. Así, el término "agente de protección contra los rayos UV-A convencional" se refiere también a los derivados de dibenzoilmetano como por ejemplo PARSOL® 1789 estabilizados, por ejemplo, mediante derivados de 3,3-difenilacrilato como se describe en EP 514,491 y EP 780,119; derivados de bencilideno alcanfor como se describe en US 5,605, 680; organosiloxanos que contienen grupos benzmalonato como se describe en EP 358,584, EP 538,431 y EP 709,080.How dibenzoylmethane derivatives have limited photo-stability may be desirable photo-stabilize these protective agents against UV-A rays Thus, the term "agent of protection against conventional UV-A rays " also refers to dibenzoylmethane derivatives as per example PARSOL® 1789 stabilized, for example, by derivatives of 3,3-diphenylacrylate as described in EP 514,491 and EP 780,119; camphor benzylidene derivatives as described in US 5,605,680; organosiloxanes containing groups benzmalonate as described in EP 358,584, EP 538,431 and EP 709,080.
Las composiciones de la invención también pueden contener adyuvantes y aditivos cosméticos habituales, como conservantes/antioxidantes, sustancias grasas/aceites, agua, solventes orgánicos, siliconas, espesantes, suavizantes, emulsionantes, protectores solares adicionales, agentes antiespumantes, hidratantes, fragancias, tensioactivos, rellenos, agentes secuestrantes, polímeros aniónicos, catiónicos, no iónicos o anfóteros o sus mezclas, propulsores, agentes acidificantes o basificantes, tintes, colorantes, pigmentos o nanopigmentos, en particular aquellos adecuados para proporcionar un efecto foto-protector adicional al bloquear físicamente la radiación ultravioleta, o cualquier otro ingrediente normalmente formulado en los cosméticos, en particular para la producción de composiciones protectoras solares/anti-solar. Las cantidades necesarias de los adyuvantes dermatológicos y cosméticos y los aditivos, en base al producto deseado, pueden ser fácilmente escogidas por una persona experta en este campo y será ilustrado en los ejemplos, sin estar limitadas a estos.The compositions of the invention can also contain usual cosmetic adjuvants and additives, such as preservatives / antioxidants, fatty substances / oils, water, organic solvents, silicones, thickeners, softeners, emulsifiers, additional sunscreens, agents defoamers, moisturizers, fragrances, surfactants, fillers, sequestering agents, anionic, cationic, non-ionic polymers or amphoteric or mixtures thereof, propellants, acidifying agents or Basifying agents, dyes, dyes, pigments or nanopigments, in particular those suitable to provide an effect additional photo-protector by physically blocking the ultraviolet radiation, or any other ingredient normally formulated in cosmetics, in particular for the production of sunscreen / sunscreen compositions. The necessary amounts of dermatological and cosmetic adjuvants and the additives, based on the desired product, can easily be chosen by an expert in this field and will be illustrated in the examples, without being limited to these.
Una cantidad adicional de antioxidantes/conservantes es generalmente preferida. Todos los antioxidantes conocidos usualmente formulados en los cosméticos pueden ser usados. Especialmente preferidos son los antioxidantes escogidos del grupo formado por aminoácidos (por ejemplo, la glicina, histidina, tirosina, triptófano) y sus derivados, imidazol (por ejemplo ácido urocánico) y derivados, péptidos tales como D,L-carnosina, D-carnosina, L-carnosina y derivados (por ejemplo, anserina), carotinoides, carotenos (por ejemplo, \alpha-caroteno, \beta-caroteno, licopeno) y derivados, ácido clorogénico y derivados, ácido lipónico y derivados (por ejemplo, ácido dihidrolipónico), aurotioglucosa, propiltiouracil y otros tioles (por ejemplo, tioredoxina, glutatión, cisteína, cistina, cistamina y sus glicosil-, N-acetil-, metil-, etil-, propil-, amil-, butil- y lauril-, palmitoil-; oleiil-, \gamma-linoleil, colesteril y gliceriléter) y sales de los mismos, dilauriltiodipropionato, disteariltiodipropionato, y ácido tiodiopropiónico y sus derivados (éster, éter, péptidos, lípidos, nucleótidos, nucleósidos y sales), así como los compuestos de sulfoximina (como butionina sulfoximina, homocisteína sulfoximina, butionina sulfona, penta-, hexa-, heptationina sulfoximina) en dosis muy bajas compatibles (por ejemplo, pmol/kg a \mumol/kg), adicionalmente (metal)-quelantes (como ácidos grasos \alpha-hidroxi, palmítico, ácido fitínico, lactoferrina), \alpha-hidroxiácidos (como el ácido cítrico, ácido láctico, ácido málico), ácido humínico, ácido gálico, extractos gálicos, bilirrubina, biliverdina, EDTA, EGTA y sus derivados, ácidos grasos no saturados y sus derivados (tales como, ácido \gamma-linoleico, ácido linólico, ácido oleico), ácido fólico y sus derivados, ubiquinona y ubiquinol y sus derivados, vitamina C y derivados (como ascorbil palmitato y ascorbil tetraisopalmitato, fosfato de ascorbil Mg, fosfato de ascorbil Na, ascorbil acetato), tocoferol y sus derivados (como el acetato de vitamina E, nat. vitamina E y mezclas de los mismos), la vitamina A y sus derivados (acetato y palmitato de vitamina A), así como coniferilbenzoato, ácido rutínico y derivados, rutin \alpha-glicosil, ácido ferúlico, glucitol furfurilideno, butil hidroxitolueno, butil hidroxianisol, trihidroxibutirofenona, urea y sus derivados, manosa y derivados, zinc y derivados (por ejemplo, ZnO, ZnSO_{4}), selenio y derivados (por ejemplo, seleniometionina) estilbenos y derivados (como estilbenóxido, trans- estilbenóxido) y derivados adecuados (sales, ésteres, éteres, azúcares, nucleótidos, nucleósidos, péptidos y lípidos) de los ingredientes activos nombrados. Uno o más conservantes/antioxidantes pueden estar presentes en una cantidad de alrededor de 0.01% en peso a alrededor de 10% en peso del peso total de la composición de la presente invención. Preferiblemente, uno o más conservantes/antioxidantes están presentes en una cantidad de alrededor de 0.1% en peso a alrededor de 1% en peso.An additional amount of Antioxidants / preservatives is generally preferred. All the known antioxidants usually formulated in cosmetics They can be used. Especially preferred are antioxidants chosen from the group consisting of amino acids (for example, the glycine, histidine, tyrosine, tryptophan) and its derivatives, imidazole (for example urocanic acid) and derivatives, peptides such as D, L-carnosine, D-carnosine, L-carnosine and derivatives (for example, anserine), carotinoids, carotenes (for example, α-carotene, β-carotene, lycopene) and derivatives, acid chlorogenic and derivatives, liponic acid and derivatives (for example, dihydroliponic acid), aurothioglucose, propylthiouracil and others thiols (e.g., thioredoxin, glutathione, cysteine, cystine, cystamine and its glycosyl-, N-acetyl-, methyl-, ethyl-, propyl-, amyl-, butyl- and lauryl-, palmitoyl-; oleiil-, γ-linoleil, cholesterol and glyceryl ether) and salts thereof, dilaurylthiopropionate, distearyl thiopropionate, and thiodiopropionic acid and its derivatives (ester, ether, peptides, lipids, nucleotides, nucleosides and salts), as well as sulfoximin compounds (such as butionine sulfoximin, homocysteine sulfoximin, butionine sulfone, penta-, hexa-, heptathione sulfoximin) in very low doses compatible (for example, pmol / kg to umol / kg), additionally (metal) - chelants (as fatty acids α-hydroxy, palmitic, phytinic acid, lactoferrin), α-hydroxy acids (such as acid citric, lactic acid, malic acid), humic acid, acid Gallic, gallic extracts, bilirubin, biliverdin, EDTA, EGTA and its derivatives, unsaturated fatty acids and its derivatives (such as, γ-linoleic acid, linolic acid, oleic acid), folic acid and its derivatives, ubiquinone and ubiquinol and its derivatives, vitamin C and derivatives (such as ascorbyl palmitate and ascorbyl tetraisopalmitate, ascorbyl phosphate Mg, phosphate ascorbil Na, ascorbil acetate), tocopherol and its derivatives (such as Vitamin E acetate, nat. vitamin E and mixtures thereof), the vitamin A and its derivatives (vitamin A acetate and palmitate), as well such as coniferylbenzoate, rutinic acid and derivatives, rutin α-glycosyl, ferulic acid, glucitol furfurylidene, butyl hydroxytoluene, butyl hydroxyanisole, trihydroxybutyrophenone, urea and its derivatives, mannose and derivatives, zinc and derivatives (for example, ZnO, ZnSO4), selenium and derivatives (for example, seleniomethionine) stilbenes and derivatives (such as stilbenexide, trans-stilbenexide) and suitable derivatives (salts, esters, ethers, sugars, nucleotides, nucleosides, peptides and lipids) of the active ingredients named. One or more preservatives / antioxidants may be present in an amount from about 0.01% by weight to about 10% by weight by weight Total composition of the present invention. Preferably, one or more preservatives / antioxidants are present in a amount from about 0.1% by weight to about 1% by weight.
Los ejemplos de emulsionantes que pueden ser
usados en la presente invención, a fin de formar emulsiones/
microemulsiones O/W, W/O, O/W/O ó W/O/W incluyen el oleato de
sorbitol, sesquioleato de sorbitol, isoestearato de sorbitol,
trioleato de sorbitol,
poligliceril-3-diisoestearato,
ésteres de poli-glicerol de ácido
oleico/isoesteárico, poligliceril-6 hexaricinolato,
poligliceril-4-oleato,
poligliceril-4 oleato/PEG-8
propilenglicol cocoato, oleamida DEA, miristato de TEA, estearato
de TEA, estearato de magnesio, estearato de sodio, laurato de
potasio, ricinoleato de potasio, cocoato de sodio, cebato de sodio,
castorato de potasio, oleato de sodio, y mezclas de los mismos.
Emulsionantes adecuados adicionales son los ésteres de fosfato y las
sales de los mismos, como el cetil fosfato (Amphisol® A), cetil
fosfato de dietanolamina (Amphisol®), cetil fosfato de potasio
(Amphisol® K), fosfato de sodio gliceril oleato, fosfato de
glicéridos vegetales hidrogenados y mezclas de los mismos. Por otra
parte, uno o más polímeros sintéticos pueden ser usados como un
emulsionante. Por ejemplo, copolímero PVP eicoseno, crospolímero de
acrilatos/C_{10-30}-alquil
acrilato, copolímero de acrilatos/steareth-20
metacrilato, copolímero de PEG-22/dodecil glicol,
copolímero de PEG-45/dodecil glicol, y mezclas de
los mismos. Los emulsionantes preferidos son el cetil fosfato
(Amphisol® A), cetil fosfato de dietanolamina (Amphisol®), cetil
fosfato de potasio (Amphisol® K), copolímero PVP eicoseno,
crospolímero de
acrilatos/C_{10-30}-alquil
acrilato, PEG-20 sorbitol isoestearato, isoestearato
de sorbitol, y mezclas de los mismos. Los emulsionantes están
presentes en una cantidad total de alrededor de 0.01% en peso a
alrededor de 20% en peso del peso total de la composición de la
presente invención. De preferencia, alrededor de 0.1% en peso a
alrededor de 10% en peso de emulsionante son usados.Examples of emulsifiers that can be used in the present invention, in order to form emulsions /
O / W, W / O, O / W / O or W / O / W microemulsions include sorbitol oleate, sorbitol sesquioleate, sorbitol isostearate, sorbitol trioleate, polyglyceryl-3-diisoesterate, polyglycerol esters of oleic / isostearic acid, polyglyceryl-6 hexaricinolate, polyglyceryl-4-oleate, polyglyceryl-4 oleate / PEG-8 propylene glycol cocoate, DEA oleamide, TEA myristate, TEA stearate, magnesium stearate, sodium stearate, potassium laurate potassium ricinoleate, sodium cocoate, sodium cebato, potassium castorate, sodium oleate, and mixtures thereof. Additional suitable emulsifiers are phosphate esters and salts thereof, such as cetyl phosphate (Amphisol® A), diethanolamine cetyl phosphate (Amphisol®), potassium cetyl phosphate (Amphisol® K), sodium glyceryl oleate phosphate, hydrogenated vegetable glyceride phosphate and mixtures thereof. On the other hand, one or more synthetic polymers can be used as an emulsifier. For example, PVP eicosenne copolymer, acrylate crospolymer / C 10-30 -alkyl acrylate, acrylate / steareth-20 methacrylate copolymer, PEG-22 / dodecyl glycol copolymer, PEG-45 / dodecyl glycol copolymer, and mixtures thereof. Preferred emulsifiers are cetyl phosphate (Amphisol® A), diethanolamine cetyl phosphate (Amphisol®), potassium cetyl phosphate (Amphisol® K), PVP eicosenne copolymer, acrylate / C 10-30 alkyl acrylate cpolymer, PEG-20 sorbitol isostearate, sorbitol isostearate, and mixtures thereof. Emulsifiers are present in a total amount of about 0.01% by weight to about 20% by weight of the total weight of the composition of the present invention. Preferably, about 0.1% by weight to about 10% by weight of emulsifier are used.
La fase de lípidos puede ser ventajosamente escogida de: los aceites minerales y ceras minerales; aceites como los triglicéridos de ácido caprínico o ácido caprílico, de preferencia aceite de ricino; aceites o ceras y otros aceites naturales o sintéticos, en una realización preferida ésteres de ácidos grasos con alcoholes por ejemplo isopropanol, propileno glicol, glicerina o ésteres de alcoholes grasos con ácidos carboxílicos inferiores o ácidos grasos; alquil benzoatos; aceites de silicona como dimetilpolisiloxano, dietilpolisiloxano, difenilpolisiloxano, ciclometicona y mezclas de los mismos.The lipid phase can be advantageously chosen from: mineral oils and mineral waxes; oils like triglycerides of caprinic acid or caprylic acid, of castor oil preference; oils or waxes and other oils natural or synthetic, in a preferred embodiment esters of fatty acids with alcohols for example isopropanol, propylene glycol, glycerin or esters of fatty alcohols with acids lower carboxylic or fatty acids; alkyl benzoates; oils silicone such as dimethylpolysiloxane, diethylpolysiloxane, diphenylpolysiloxane, cyclomethicone and mixtures thereof.
Las sustancias grasas ejemplares que pueden ser incorporadas en la fase oleosa de la emulsión, microemulsión, oleo gel, hidrodispersión o lipodispersión de la presente invención son ventajosamente escogidas a partir de ésteres de ácidos alquil carboxílicos lineales o ramificados saturados y/o no saturados con 3 a 30 átomos de carbono y alcoholes lineales y/o ramificados saturados y/o no saturados con 3 a 30 átomos de carbono, así como los ésteres de ácidos carboxílicos aromáticos y de alcoholes lineales o ramificados saturados y/o no saturados, de 3-30 átomos de carbono. Estos ésteres pueden ventajosamente ser seleccionados de octil palmitato, octil-cocoato, octil isostearato, octil dodecil miristato, cetearilisononanoato, isopropil miristato, isopropil palmitato, isopropil estearato, isopropil oleato, n-butil estearato, n-hexil laureato, n-deciloleato, isooctil estearato, isononil estearato, isononil isononanoato, 2-etil hexil palmitato, 2-etilhexil laureato, 2-hexildecil estearato, 2-octil dodecil palmitato, estearil heptanoato, oleiloleato, oleilerucato, eruciloleato, erucilerucato tridecil estearato, tridecil trimelitato, y mezclas sintéticas, semi-sintéticas o naturales de dichos ésteres por ejemplo el aceite de jojoba.Exemplary fatty substances that can be incorporated into the oil phase of the emulsion, microemulsion, oil gel, hydrodispersion or lipodispersion of the present invention are advantageously chosen from alkyl acid esters linear or branched carboxylic acids saturated and / or unsaturated with 3 at 30 carbon atoms and linear and / or branched alcohols saturated and / or unsaturated with 3 to 30 carbon atoms, as well as esters of aromatic carboxylic acids and alcohols linear or branched saturated and / or unsaturated, of 3-30 carbon atoms. These esters can advantageously being selected from octyl palmitate, octyl cocoate, octyl isostearate, octyl dodecil myristate, cetearylisononanoate, isopropyl myristate, isopropyl palmitate, isopropyl stearate, isopropyl oleate, n-butyl stearate, n-hexyl laureate, n-decyloleate, isooctyl stearate, isononyl stearate, isononyl isononanoate, 2-ethyl hexyl palmitate, 2-ethylhexyl laureate, 2-hexyldecyl stearate, 2-octyl dodecyl palmitate, stearyl heptanoate, oleyl oleate, oleilerucate, eruciloleato, tridecil stearate erucilerucato, tridecil trimellitate, and synthetic, semi-synthetic mixtures or natural of said esters for example jojoba oil.
Otros componentes grasos adecuados para su uso en la formulación de la presente invención incluyen los aceites polares como lecitinas y triglicéridos de ácidos grasos, a saber ésteres triglicerínicos de ácido carbónico lineal o ramificado saturado y/o no saturado, con 8 a 24 átomos de carbono, preferiblemente de 12 a 18 átomos de carbono, mientras que los triglicéridos de ácidos grasos son preferiblemente escogidos entre los aceites sintéticos, semi-sintéticos o naturales (por ejemplo, cocoglicérido, aceite de oliva, aceite de girasol, aceite de soja, aceite de maní, aceite de semilla de colza, aceite de almendra dulce, aceite de palma, aceite de coco, aceite de ricino, aceite de ricino hidrogenado, aceite de trigo, aceite de semilla de uva, aceite de nuez de macadamia y otros); aceites apolares como los hidrocarburos lineales y/o ramificados y ceras por ejemplo aceites minerales, vaselina (petrolato); parafinas, squalan y squalen, poliolefinas, isohexadecanos y poliisobutenos hidrogenados, las poliolefinas favorecidos son polidecenos; dialquil éteres como dicaprililéter; aceites de silicona lineales o cíclicos, tales como preferiblemente ciclometicona (octametil ciclotetrasiloxano), cetil dimeticona, hexametil ciclotrisiloxano, polidimetil siloxano, poli(metil fenil siloxano) y mezclas de los mismos.Other fatty components suitable for use in the formulation of the present invention include oils polar such as fatty acid lecithins and triglycerides, namely Triglycerinic esters of linear or branched carbonic acid saturated and / or unsaturated, with 8 to 24 carbon atoms, preferably from 12 to 18 carbon atoms, while the fatty acid triglycerides are preferably chosen from synthetic, semi-synthetic or natural oils (for example, cocoglyceride, olive oil, sunflower oil, soybean oil, peanut oil, rapeseed oil, oil Sweet almond, palm oil, coconut oil, oil castor, hydrogenated castor oil, wheat oil, grape seed, macadamia nut oil and others); oils apolar such as linear and / or branched hydrocarbons and waxes by example mineral oils, petrolatum (petrolatum); paraffins, squalan and squalen, polyolefins, isohexadecanes and polyisobutenes hydrogenated, the favored polyolefins are polydecenes; dialquil ethers such as dicaprilyl ether; linear silicone oils or cyclic, such as preferably cyclomethicone (octamethyl cyclotetrasiloxane), cetyl dimethicone, hexamethyl cyclotrisiloxane, polydimethyl siloxane, poly (methyl phenyl siloxane) and mixtures of the same.
Aún otros componentes grasos que pueden ser ventajosamente incorporados en las formulaciones de la presente invención incluyen isoeicosano; neopentilglicol diheptanoato; propileno glicol dicaprilato/dicaprato; digliceril succinato caprílico/cáprico; butileno glicol caprilato/caprato; C_{l2-15}-alquil lactatos; di-C_{l2-15}-alquil tartratos; triisoestearin; dipentaeritritil hexacaprilato/hexacaprato; propileno glicol monoisoetearato; tricaprilin; dimetil isosorbide. Especialmente beneficioso es el uso de mezclas de C_{l2-15}-alquilbenzoatos y 2-etil-hexilisoestearato, mezclas de C_{l2-15}-alquilbenzoatos e isotridecilisononanoato así como las mezclas de C_{l2-15}-alquilbenzoatos, 2-etilhexilisoestearato e isotridecilisononanoato.Still other fatty components that can be advantageously incorporated in the formulations herein invention include isoeicosan; neopentyl glycol diheptanoate; propylene glycol dicaprilate / dicaprate; diglyceryl succinate caprylic / capric; butylene glycol caprylate / caprate; C2-15 -alkyl lactates; di-C_2-15} -alkyl tartrates; triisoestearin; dipentaerythrityl hexacaprilat / hexacaprate; propylene glycol monoisoetearate; tricaprilin; dimethyl isosorbide. Especially beneficial is the use of mixtures of C_2-15} -alkylbenzoates and 2-ethyl-hexyl isoestearate, mixtures of C_2-15} -alkylbenzoates e isotridecylisononanoate as well as mixtures of C_2-15} -alkylbenzoates, 2-ethylhexyl isoestearate e isotridecylisononanoate.
La fase oleosa de la formulación de la presente invención también puede contener ceras animales o vegetales naturales como la cera de abeja, cera de porcelana, cera de abejorros y otras ceras de insectos, así como manteca de karité y manteca de cacao.The oil phase of the formulation of the present invention may also contain animal or vegetable waxes natural as beeswax, porcelain wax, wax bumblebees and other insect waxes, as well as shea butter and cocoa butter
Un agente hidratante puede ser incorporado a una composición de la presente invención para mantener la hidratación o re-hidratar la piel. Los humectantes que evitan que el agua se evapore de la piel, proporcionando una capa protectora se denominan emolientes. Adicionalmente, un emoliente proporciona un efecto calmante o ablandamiento sobre la superficie de la piel y es generalmente considerado seguro para uso tópico. Los emolientes preferidos incluyen los aceites minerales, lanolina, petrolato, trigliceraldehídos caprílicos, cápricos, colesterol, siliconas, como la dimeticona, ciclometilicona, aceite de almendras, aceite de jojoba, aceite de aguacate, aceite de ricino, aceite de sésamo, aceite de girasol, aceite de coco y aceite de semilla de uva, manteca de cacao, extractos de aloe de aceite de oliva, ácidos grasos como el oleico y esteárico, alcoholes grasos como cetil y hexadecilalcohol, diisopropil adipato, ésteres de hidroxi benzoato, ésteres de ácido benzoico de C_{9-15}-alcoholes, isononil iso-nonanoato, éteres como poli- oxipropileno butil éteres y polioxipropileno cetil ésteres, y C_{l2-15}-alquil benzoato, y mezclas de los mismos. Los emolientes más preferidos son ésteres de hidroxibenzoato, aloe vera, C_{l2-15}-alquil benzoatos, y mezclas de los mismos. Un emoliente puede estar presente en una cantidad de alrededor de 1% en peso a alrededor de 20% en peso del peso total de la composición. La cantidad preferida de emoliente puede ser de alrededor de 2% en peso a alrededor de 15% en peso, y más preferiblemente alrededor de 4% en peso a alrededor de 10% en peso.A moisturizing agent can be incorporated into a composition of the present invention to maintain hydration or Rehydrate the skin. The humectants that prevent water evaporates from the skin, providing a protective layer They are called emollients. Additionally, an emollient provides a soothing or softening effect on the skin's surface and is Generally considered safe for topical use. Emollients Preferred include mineral oils, lanolin, petrolatum, triglycaraldehydes, capric, capric, cholesterol, silicones, such as dimethicone, cyclomethylicone, almond oil, jojoba, avocado oil, castor oil, sesame oil, sunflower oil, coconut oil and grapeseed oil, cocoa butter, olive oil aloe extracts, acids fatty like oleic and stearic, fatty alcohols like cetil and hexadecylalcohol, diisopropyl adipate, hydroxy benzoate esters, esters of benzoic acid from C_ {15-15} -alcohols, isononyl iso-nonanoate, ethers such as polypropylene butyl ethers and polyoxypropylene cetyl esters, and C1-15-15 -alkyl benzoate, and mixtures thereof. The most preferred emollients are esters of hydroxybenzoate, aloe vera, C_2-15} -alkyl benzoates, and mixtures thereof. An emollient may be present in a amount from about 1% by weight to about 20% by weight of total weight of the composition. The preferred amount of emollient it can be from about 2% by weight to about 15% by weight, and more preferably about 4% by weight to about 10% in weight.
Los hidratantes que se unen al agua, reteniéndola en la superficie de la piel se denominan humectantes. Los humectantes adecuados pueden ser incorporados en una composición de la presente invención, como la glicerina, polipropileno glicol, polietileno glicol, ácido láctico, ácido carboxílico pirrolidón, urea, fofolípidos, colágeno, elastina, ceramidas, lecitina, sorbitol, PEG-4, y mezclas de los mismos. Los hidratantes adicionales adecuados son hidratantes poliméricos de la familia de los polisacáridos solubles en agua y/o hinchables y/o que forman una gelatina con el agua, como el ácido hialurónico, quitosano y/o un polisacárido rico en fucosa el cual está, por ejemplo, disponible como Fucogel® 1000 (CAS-Nr. 178463-23-5) por SOLABIA S. Uno o más humectantes están opcionalmente presentes en alrededor de 0.5% en peso a alrededor de 8% en peso en una composición de la presente invención, preferiblemente alrededor de 1% en peso a alrededor de 5% en peso.Moisturizers that bind to water, retaining it on the surface of the skin are called moisturizers. Suitable humectants can be incorporated into a composition of the present invention, such as glycerin, polypropylene glycol, polyethylene glycol, lactic acid, acid carboxylic pyrrolidon, urea, phospholipids, collagen, elastin, ceramides, lecithin, sorbitol, PEG-4, and mixtures of the same. Suitable additional moisturizers are moisturizers. polymers of the family of water-soluble polysaccharides and / or inflatable and / or forming a jelly with water, such as acid hyaluronic, chitosan and / or a rich fucose polysaccharide which It is, for example, available as Fucogel® 1000 (CAS-Nr. 178463-23-5) by SOLABIA S. One or more humectants are optionally present at around 0.5% by weight to about 8% by weight in a composition of the present invention, preferably about 1% by weight to about 5% in weigh.
La fase acuosa de las composiciones de la presente invención puede contener aditivos cosméticos habituales, tales como alcoholes, alcoholes especialmente inferiores, preferiblemente etanol y/o iso-propanol, polioles del orden de los dioles inferiores y sus éteres, preferiblemente propileno glicoles, glicerina, etilenglicol, etilenglicol monoetil o monobutil éter, propileno glicol-mono-metil-, monoetil-, o monobutil éter, dietileno glicol-monometil- o monoetil- éter y productos análogos, polímeros, estabilizadores de espuma; electrolitos y especialmente uno o más espesantes. Los espesantes adecuados que pueden ser usados en las formulaciones de la presente invención para ayudar en la toma de consistencia de un producto incluyen carbómero, dióxido de silicio, silicatos de magnesio y/o aluminio, cera de abejas, ácido esteárico, alcohol estearílico polisacáridos y sus derivados como la goma de xantano, hidroxipropil celulosa, poliacrilamidas, crospolímeros de acrilato preferiblemente un carbopol, como el carbopol de tipo 980, 981, 1382, 2984, 5984 solo o mezclas de los mismos. Los agentes neutralizantes adecuados que pueden ser incluidos en la composición de la presente invención para neutralizar los componentes tales como por ejemplo un emulsionante o un formador/estabilizador de espuma incluyen pero no están limitados a hidróxidos alcalinos como el hidróxido de potasio y sodio; bases orgánicas tales como la dietanolamina (DEA), trietanolamina (TEA), aminometil propanol, y mezclas de los mismos; aminoácidos como la arginina y de la lisina y cualquier combinación de los anteriores. El agente de neutralización puede estar presente en una cantidad de alrededor de 0.01% en peso a alrededor de 8% en peso en la composición de la presente invención, preferiblemente, de 1% en peso a alrededor de 5% en peso.The aqueous phase of the compositions of the The present invention may contain usual cosmetic additives, such as alcohols, especially lower alcohols, preferably ethanol and / or iso-propanol, polyols of the order of the lower diols and their ethers, preferably propylene glycols, glycerin, ethylene glycol, ethylene glycol monoethyl or monobutyl ether, propylene glycol-mono-methyl-, monoethyl-, or monobutyl ether, diethylene glycol-monomethyl- or monoethyl ether and similar products, polymers, stabilizers foam; electrolytes and especially one or more thickeners. The suitable thickeners that can be used in the formulations of the present invention to assist in the consistency of a Product include carbomer, silicon dioxide, silicates magnesium and / or aluminum, beeswax, stearic acid, alcohol stearyl polysaccharides and their derivatives such as xanthan gum, hydroxypropyl cellulose, polyacrylamides, acrylate crospolymers preferably a carbopol, such as carbopol type 980, 981, 1382, 2984, 5984 alone or mixtures thereof. The agents suitable neutralizers that can be included in the composition of the present invention to neutralize such components such as an emulsifier or a former / stabilizer foam include but are not limited to alkali hydroxides such as potassium and sodium hydroxide; organic bases such as the diethanolamine (DEA), triethanolamine (TEA), aminomethyl propanol, and mixtures thereof; amino acids such as arginine and lysine and any combination of the above. The agent of neutralization may be present in an amount of about 0.01% by weight to about 8% by weight in the composition of the present invention, preferably, from 1% by weight to about 5% in weigh.
La adición de electrolitos en la composición de la presente invención puede ser necesaria para cambiar el comportamiento de un emulsionante hidrofóbico. Así, las emulsiones/microemulsiones de esta invención pueden contener preferiblemente electrolitos de una o varias sales incluyendo aniones tales como cloruro, un sulfato, un carbonato, un borato o un aluminato, sin estar limitados a estos. Otros electrolitos adecuados puede ser sobre la base de aniones orgánicos, tales como, pero no limitado a, lactato, acetato, benzoato, propionato, tartrato y citrato. Como los cationes de amoníaco, preferiblemente son seleccionados el alquilamonio, metales alcalinos o alcalinos térreos, iones de magnesio, hierro o zinc. Las sales especialmente preferidas son el cloruro de sodio y potasio, sulfato de magnesio, sulfato de zinc y mezclas de las mismas. Los electrolitos están presentes en una cantidad de alrededor de 0.01% en peso a alrededor de 8% en peso en la composición de la presente invención.The addition of electrolytes in the composition of the present invention may be necessary to change the behavior of a hydrophobic emulsifier. So, the Emulsions / microemulsions of this invention may contain preferably electrolytes of one or more salts including anions such as chloride, a sulfate, a carbonate, a borate or an aluminate, without being limited to these. Other electrolytes Suitable may be based on organic anions, such as, but not limited to, lactate, acetate, benzoate, propionate, Tartrate and citrate. Like ammonia cations, preferably alkylammonium, alkali or alkali metals are selected Earth, magnesium, iron or zinc ions. The salts especially Preferred are sodium and potassium chloride, magnesium sulfate, zinc sulfate and mixtures thereof. The electrolytes are present in an amount of about 0.01% by weight to about 8% by weight in the composition of the present invention.
Las composiciones cosméticas de la invención son útiles como composiciones para la foto-protección de la epidermis humana o el cabello contra los efectos nocivos de la radiación ultravioleta, como composición protectora solar/anti-solar, o como producto de maquillaje. Tales composiciones pueden, en particular, ser proporcionadas en forma de una loción, una crema espesa, un gel, una crema, una leche, una pomada, un polvo o una barra en forma de tubo sólida, y opcionalmente pueden ser envasadas en forma de aerosol y pueden ser proporcionadas en forma de una crema, espuma o un aerosol. Cuando la composición cosmética de acuerdo con la invención es proporcionada para la protección de la epidermis humana contra la radiación UV o como una composición protectora solar/anti-solar, puede estar en forma de una suspensión o dispersión en los solventes o sustancias grasas, o como alternativa, en forma de una emulsión o microemulsión (en particular, de tipo O/W o W/O, de tipo O/W/O ó W/O/W), como una crema o una leche, una dispersión vesicular, en forma de una pomada, un gel, una barra en forma de tubo sólida o una crema en aerosol. Las emulsiones también pueden contener tensioactivos aniónicos, no iónicos, catiónicos o anfóteros.The cosmetic compositions of the invention are useful as compositions for the photo-protection of the human epidermis or hair against the harmful effects of the ultraviolet radiation, as a protective composition solar / anti-solar, or as a makeup product. Such compositions may, in particular, be provided in form of a lotion, a thick cream, a gel, a cream, a milk, an ointment, a powder or a solid tube shaped bar, and optionally they can be packaged in aerosol form and can be provided in the form of a cream, foam or a spray. When The cosmetic composition according to the invention is provided for the protection of the human epidermis against UV radiation or as a protective composition solar / anti-solar, can be in the form of a suspension or dispersion in solvents or fatty substances, or as alternative, in the form of an emulsion or microemulsion (in particular, of type O / W or W / O, of type O / W / O or W / O / W), as a cream or a milk, a vesicular dispersion, in the form of an ointment, a gel, a solid tube shaped bar or a spray cream. Emulsions may also contain anionic surfactants, not ionic, cationic or amphoteric.
Cuando la composición cosmética de acuerdo con la invención se usa para proteger el cabello, puede estar en forma de una champú, una loción, un gel o una composición de enjuague, a ser aplicada antes o después del champú, antes o después del tinte o la decoloración, antes, durante o después de la operación de alisamiento del cabello o la ondulación permanente, una loción o gel de tratamiento o estilista, una loción o un gel para el secado por aire o arreglo del cabello, una laca para el cabello, o una composición para la ondulación permanente, alisado, tinte o decoloración del cabello.When the cosmetic composition according to The invention is used to protect the hair, it can be in shape of a shampoo, lotion, gel or rinse composition, to be applied before or after shampoo, before or after dye or discoloration, before, during or after the operation of hair straightening or perm, a lotion or treatment gel or stylist, a lotion or a gel for drying by air or hair arrangement, a hairspray, or a Composition for perm, straightening, dyeing or hair discoloration
\global\parskip0.930000\baselineskip\ global \ parskip0.930000 \ baselineskip
Cuando la composición cosmética de acuerdo con la invención se usa como producto de maquillaje para las pestañas, las cejas, la piel o el cabello, como una crema de tratamiento epidérmico, una base, un tubo de lápiz labial, una sombra de ojos, un polvo facial, un delineador de ojos, una máscara o un gel de color, ésta puede ser sólida o pastosa, anhidra o en forma acuosa, como emulsión O/W o W/O, suspensión o gel.When the cosmetic composition according to The invention is used as a makeup product for eyelashes, eyebrows, skin or hair, as a treatment cream epidermal, a base, a tube of lipstick, an eye shadow, a face powder, an eyeliner, a mask or a gel color, this can be solid or pasty, anhydrous or in aqueous form, as an O / W or W / O emulsion, suspension or gel.
La presente invención también incluye la formulación de los compuestos organosilícicos de acuerdo con la invención como un agente para la protección de la radiación UV, en particular, para controlar el color de la piel humana.The present invention also includes the formulation of organosilicon compounds according to the invention as an agent for the protection of UV radiation, in particular, to control the color of human skin.
Los compuestos organosilícicos de acuerdo con la presente invención muestran una excelente solubilidad en grasas y por lo tanto pueden ser incorporados en altas concentraciones en las formulaciones cosméticas que conducen a un factor de protección elevado de las composiciones finales. Además, los mismos son homogéneamente distribuidos en la formulación cosmética conteniendo al menos una fase de grasa y un solvente orgánico cosméticamente aceptado que conduce, cuando se aplica sobre la piel o el cabello, a la formación de una película protectora que protege eficazmente la piel y/o el cabello contra los efectos nocivos de la radiación UV.The organosilicon compounds according to the present invention show excellent fat solubility and therefore they can be incorporated in high concentrations in the cosmetic formulations that lead to a protective factor elevated of the final compositions. In addition, they are homogeneously distributed in the cosmetic formulation containing at least one phase of fat and a cosmetically organic solvent accepted that leads, when applied to the skin or hair, to the formation of a protective film that effectively protects the skin and / or hair against the harmful effects of radiation UV
Así, es otro objeto de la presente invención el uso de los compuestos de la invención para proteger la piel y/o el cabello de la radiación ultravioleta, en particular, la radiación solar, que comprende la aplicación tópica de una cantidad efectiva de una composición cosmética que contiene los compuestos organosilícicos de acuerdo con la invención.Thus, it is another object of the present invention the use of the compounds of the invention to protect the skin and / or the ultraviolet radiation hair in particular radiation solar, which includes the topical application of an effective amount of a cosmetic composition containing the compounds organosilicon according to the invention.
Por último, la presente invención también caracteriza el régimen no terapéutico/régimen de control de la variación del color de la piel causada por la radiación ultravioleta, que comprende la aplicación tópica en la piel de una cantidad efectiva de una composición cosmética que contiene los compuestos organosilícicos de acuerdo con la invención.Finally, the present invention also characterizes the non-therapeutic regimen / control regime of the variation of skin color caused by radiation ultraviolet, which includes topical application on the skin of a effective amount of a cosmetic composition containing the organosilicon compounds according to the invention.
De acuerdo con otra realización de la invención, un compuesto organosilícico de esta invención puede ser usado como agente protector contra la radiación UV para plásticos.According to another embodiment of the invention, An organosilicon compound of this invention can be used as UV protective agent for plastics.
Los derivados organosilícicos de la invención son también foto-estables.The organosilicon derivatives of the invention They are also photo-stable.
De acuerdo con lo anterior, la invención proporcionaIn accordance with the foregoing, the invention provides
(1) Un compuesto organosilícico para su uso como un filtro de rayos UVA, por ejemplo, para su uso en una composición cosmética;(1) An organosilicon compound for use as a UVA filter, for example, for use in a composition cosmetic
(2) Una composición cosmética que comprende un compuesto organosilícico como en (1) como ingrediente activo, junto con adyuvantes cosméticamente aceptados y aditivos, en particular, una composición que comprende además un agente de protección seleccionado del grupo formado por los agentes de protección contra los rayos UV-A, los agentes de protección contra los rayos UV-B, y las mezclas de los mismos, por ejemplo, un agente de protección contra los rayos UV complementario inorgánico, como un pigmento o nanopigmento con o sin recubrimiento de un óxido de metal seleccionado de los óxidos de titanio, zinc, hierro, circonio y cerio;(2) A cosmetic composition comprising a organosilicon compound as in (1) as active ingredient, together with cosmetically accepted adjuvants and additives, in particular, a composition further comprising a protective agent selected from the group formed by protection agents UV-A rays, protective agents against UV-B rays, and mixtures thereof, by example, a complementary UV protection agent inorganic, as a pigment or nanopigment with or without coating of a metal oxide selected from the oxides of titanium, zinc, iron, zirconium and cerium;
(3) Una composición cosmética que comprende un compuesto organosilícico como en (1) como ingrediente activo junto con adyuvantes cosméticamente aceptados y aditivos para la protección del cabello humano y/o la piel contra los daños en los que la irradiación UVA desempeña un papel o está implicado;(3) A cosmetic composition comprising a organosilicon compound as in (1) as active ingredient together with cosmetically accepted adjuvants and additives for protection of human hair and / or skin against damage to that UVA irradiation plays a role or is involved;
(4) Un método para la protección del cabello humano y/o la piel contra los daños en los que la irradiación UVA desempeña un papel o que está implicada que comprende la aplicación tópica de una cantidad efectiva de un compuesto organosilícico como en (1);(4) A method for hair protection human and / or skin against damage in which UVA irradiation plays a role or that is implied that understands the application topical of an effective amount of an organosilicon compound as in 1);
(5) Uso de un compuesto organosilícico como en (1) para proteger el cabello humano y/o la piel contra los daños en los que la irradiación UVA desempeña un papel o está implicada.(5) Use of an organosilicon compound as in (1) to protect human hair and / or skin against damage to those that UVA irradiation plays a role or is involved.
Los siguientes ejemplos son proporcionados para ilustrar mejor los procesos y las composiciones de la presente invención. Estos ejemplos son ilustrativos solamente y no están destinadas a limitar el alcance de la invención de ninguna manera. En los ejemplos, FC significa cromatografía Flash; HV significa alto vacío (0.1 Pa o por debajo); INCI significa Nomenclatura Internacional de los Ingredientes Cosméticos. Todas las estructuras fueron claramente identificadas a través de ^{1}H-RMN (300 MHz, CDCl3). La foto-estabilidad de los productos se midió de acuerdo a Berset y otros; Internat. J. Cosmetic Science 18: 167-177 (1996).The following examples are provided for better illustrate the processes and compositions of this invention. These examples are illustrative only and are not intended to limit the scope of the invention in any way. In the examples, FC means Flash chromatography; HV means high vacuum (0.1 Pa or below); INCI means Nomenclature International Cosmetic Ingredients. All structures were clearly identified through 1 H-NMR (300 MHz, CDCl3). The Photo-stability of the products was measured from agreement to Berset and others; Internat. J. Cosmetic Science 18: 167-177 (1996).
Ejemplo A1Example A1
Una mezcla de 32 mmol del ácido 2-(4-dietilamino-2-hidroxibenzoil) benzoico, 160 mmol de alcohol propargílico y 32 mmol H_{2}SO_{4} es refluida durante 48 horas. Después de la evaporación del exceso de alcohol propargílico, el residuo se disuelve en acetato de etilo y, posteriormente se lava dos veces con una solución saturada de NaHCO_{3} y dos veces con agua. Después del secado (Na_{2}SO_{4}), el solvente se evapora (HV) y el producto crudo es purificado dos veces a través de FC (n-hexano/EtOAC 1:1, hexano/MTBE 4/1-1/1) produciendo prop-2-inil éster del ácido 2-(4-dietilamino-2-hidroxibenzoil) benzoico. MS (EI): 374 (18%, M + Na^{+}), 352 (100%, M + H^{+}), 296 (17%). UV (EtOH): \lambda_{máx} = 356 nm (\varepsilon= 31'648).A mixture of 32 mmol of the acid 2- (4-diethylamino-2-hydroxybenzoyl) benzoic, 160 mmol of propargyl alcohol and 32 mmol H 2 SO 4 is refluxed for 48 hours. After the evaporation of excess propargyl alcohol, the residue is Dissolve in ethyl acetate and then wash twice with a saturated solution of NaHCO3 and twice with water. After from drying (Na2SO4), the solvent evaporates (HV) and the raw product is purified twice through FC (n-hexane / EtOAC 1: 1, hexane / MTBE 4 / 1-1 / 1) producing prop-2-inyl acid ester 2- (4-diethylamino-2-hydroxybenzoyl) benzoic. MS (EI): 374 (18%, M + Na +), 352 (100%, M + H +), 296 (17%). UV (EtOH): λ max = 356 nm (? = 31'648).
\global\parskip1.000000\baselineskip\ global \ parskip1.000000 \ baselineskip
Ejemplo A2Example A2
Una mezcla de 32 mmol del ácido 2-(4-dietilamino-2-hidroxibenzoil) benzoico, 160 mmol de alcohol alílico y 32 mmol de H_{2}SO_{4} es refluida durante 48 h. Después de la evaporación del exceso de alcohol alílico el residuo se disuelve en acetato de etilo y, posteriormente se lava dos veces con una solución saturada de NaHCO_{3} y dos veces con agua. Después del secado (NaSO_{4}), el solvente es evaporado (HV) y el producto crudo es purificado a través de FC (n-hexano/EtOAC 2:1, hexano) produciendo alil éster del ácido 2-(4-dietilamino-2-hidroxibenzoil) benzoico. MS (EI): 376 (10%, M + Na^{+}), 354 (100%, M + H^{+}), 296 (17%). UV (EtOH): \lambda_{máx} = 354 nm (\varepsilon = 34'257).A mixture of 32 mmol of the acid 2- (4-diethylamino-2-hydroxybenzoyl) benzoic, 160 mmol of allyl alcohol and 32 mmol of H 2 SO 4 It is refluxed for 48 h. After evaporation of excess allyl alcohol the residue is dissolved in ethyl acetate and, subsequently washed twice with a saturated solution of NaHCO 3 and twice with water. After drying (NaSO4), The solvent is evaporated (HV) and the crude product is purified to through FC (n-hexane / EtOAC 2: 1, hexane) producing allyl acid ester 2- (4-diethylamino-2-hydroxybenzoyl) benzoic. MS (EI): 376 (10%, M + Na +), 354 (100%, M + H +), 296 (17%). UV (EtOH): λ max = 354 nm (? = 34'257).
Ejemplo A3Example A3
Una mezcla de 6 g del ácido 2-(4-dietilamino-2-hidroxibenzoil) benzoico y 1.6 g de amina propargílica se disuelve en 20 ml de DMF con enfriamiento para formar una solución clara. 5.9 g de diciclohexil carbodiimida se añade lentamente a esta solución. La mezcla se diluye con 20 ml de CH_{2}C_{l2} y se deja a temperatura ambiente durante dos horas. La suspensión formada se filtra y se lava con hexano y éter. La fase orgánica es diluida con EtOAc, lavada con solución saturada de NaHCO_{3}, tres veces con agua y una vez con solución saturada de NaCl. Después del secado (Na_{2}SO_{4}), el solvente es evaporado (HV) y el producto crudo purificado a través de FC (n-hexano/EtOAC 2:1, hexano) y recristalizado a partir de una mezcla de hexano, tolueno y EtOAc, produciendo cristales blancos de 2-(4-dietilamino-2-hidroxibenzoil)-benzamida propargílica. MS: 351 (M + H^{+}), 333.296 (100%).A mixture of 6 g of the acid 2- (4-diethylamino-2-hydroxybenzoyl) Benzoic and 1.6 g of propargyl amine is dissolved in 20 ml of DMF with cooling to form a clear solution. 5.9 g of Dicyclohexyl carbodiimide is added slowly to this solution. The mixture is diluted with 20 ml of CH2C2 and left to room temperature for two hours. The suspension formed is Filter and wash with hexane and ether. The organic phase is diluted with EtOAc, washed with saturated NaHCO3 solution, three times with water and once with saturated NaCl solution. After drying (Na 2 SO 4), the solvent is evaporated (HV) and the product purified crude via FC (n-hexane / EtOAC 2: 1, hexane) and recrystallized from a mixture of hexane, toluene and EtOAc, producing white crystals of 2- (4-diethylamino-2-hydroxybenzoyl) -benzamide propargilic MS: 351 (M + H +), 333.296 (100%).
Ejemplo B1Example B1
Una solución de 1.75 mmol de prop-2-inil éster del ácido 2-(4-dietilamino-2-hidroxibenzoil) benzoico y 1.75 mmol eq. SiH de un COMPUESTO en el que B, B', R^{1} y R^{2} son metil, Z es H, r es en su media estadística 14 y s es en su media estadística 4 (MW-1500) en 3 ml de tolueno bajo una atmósfera inerte es calentada a 55ºC. Una cantidad catalítica de platino carbono 5% es agregada y la reacción se mantiene a 55ºC durante 20 h. La solución del producto se lava con una mezcla de agua/metanol = 1:10, se seca (Na_{2}SO_{4}), y se concentra. Después que el residuo se disuelve en 3 ml de tolueno, se añade carbón activo y la mezcla se agita durante 2 d a TA. Después de la filtración sobre Celita, el solvente es evaporado para producir un aceite de color amarillo (dos isómeros). UV (EtOH): 354 nm (E = 477), teniendo solubilidad ilimitada en Cétiol LC y Crodamol DA y cualidades de foto-estabilidad excelentes en la película.A solution of 1.75 mmol of prop-2-inyl acid ester 2- (4-diethylamino-2-hydroxybenzoyl) benzoic and 1.75 mmol eq. SiH of a COMPOUND in which B, B ', R 1 and R 2 are methyl, Z is H, r is in its statistical average 14 and s is in its statistical average 4 (MW-1500) in 3 ml of toluene under an inert atmosphere is heated to 55 ° C. A Catalytic amount of 5% carbon platinum is added and the reaction it is maintained at 55 ° C for 20 h. The product solution is washed with a mixture of water / methanol = 1:10, it is dried (Na2SO4), and It concentrates. After the residue is dissolved in 3 ml of toluene, active carbon is added and the mixture is stirred for 2 d at TA After filtration on Celite, the solvent is evaporated to produce a yellow oil (two isomers). UV (EtOH): 354 nm (E = 477), having unlimited solubility in Cetiol LC and Crodamol DA and photo-stability qualities Excellent in the movie.
Ejemplo B2Example B2
0.5 g de prop-2-inil éster del ácido 2-(4-dietilamino-2-hidroxibenzoil) benzoico, 2 g de polisiloxano AE-151 de Wacker-Chemie GmbH, y una cantidad catalítica de platino carbono 5% en 10 ml de xileno se colocan en un frasco de reacción de tres cuellos bajo una atmósfera inerte y se calienta durante 2 h a 70ºC. La solución producto se filtra a través de Celita, se lava con una mezcla de agua/metanol = 1:10 y se concentra para producir un aceite de color marrón (dos isómeros). UV 354 nm (E = 147), teniendo solubilidad ilimitada en Cétiol LC y Crodamol DA y cualidades de foto-estabilidad excelentes en la película.0.5 g of prop-2-inyl acid ester 2- (4-diethylamino-2-hydroxybenzoyl) benzoic, 2 g of polysiloxane AE-151 from Wacker-Chemie GmbH, and a catalytic amount of 5% carbon platinum in 10 ml of xylene are placed in a bottle of three-necked reaction under an inert atmosphere and heats up for 2 h at 70 ° C. The product solution is filtered through Celite, washed with a mixture of water / methanol = 1:10 and concentrated to produce a brown oil (two isomers). UV 354 nm (E = 147), having unlimited solubility in Cétiol LC and Crodamol DA and excellent photo-stability qualities in the movie.
Ejemplo B3Example B3
Una solución de 1.4 mmol de 2-(4-dietilamino-2-hidroxibenzoil)-benzamida propargílica y 1.2 mmol de heptametiltrisiloxano de la fórmula IV donde B, B', R^{1} y R^{2} son metil, Z es hidrógeno, r es 0 y s es 1, en 10 ml de tolueno bajo una atmósfera inerte se calienta a 55ºC. Una cantidad del complejo platino-divinil-tetrametil-disiloxano es añadido y la reacción es mantenida a 80 a 85ºC durante 36 horas ya 100ºC durante cuatro horas. 0.3 g de heptametiltrisiloxano adicional y una pequeña cantidad de catalizador son añadidos. Después de calentar durante otras 18 horas a reflujo, la solución del producto es concentrada y cromatografiada dos veces (CH_{2}Cl_{2}/MeOH) para producir el producto (dos isómeros). UV (EtOH): 358 nm (E = 227).A solution of 1.4 mmol of 2- (4-diethylamino-2-hydroxybenzoyl) -benzamide propargyl and 1.2 mmol of heptamethyltrisiloxane of formula IV where B, B ', R 1 and R 2 are methyl, Z is hydrogen, r is 0 and s is 1, in 10 ml of toluene under an inert atmosphere is heated to 55 ° C. An amount of the complex platinum-divinyl-tetramethyl-disiloxane it is added and the reaction is maintained at 80 to 85 ° C for 36 hours and at 100 ° C for four hours. 0.3 g heptamethyltrisiloxane Additional and a small amount of catalyst are added. After heating for another 18 hours at reflux, the solution of the product is concentrated and chromatographed twice (CH 2 Cl 2 / MeOH) to produce the product (two isomers). UV (EtOH): 358 nm (E = 227).
La Parte A es calentada en un reactor a 85ºC. La Parte B es añadida lentamente dentro de los 10 minutos, seguido por la adición de KOH, enfriamiento y desgasificación de la emulsión.Part A is heated in a reactor at 85 ° C. The Part B is added slowly within 10 minutes, followed by the addition of KOH, cooling and degassing of the emulsion.
\newpage\ newpage
Ejemplo C2Example C2
La Parte A es calentada en un reactor a 85ºC. La Parte B homogénea es añadida, seguida por la adición de KOH precalentado (75ºC), enfriamiento y desgasificación de la emulsión.Part A is heated in a reactor at 85 ° C. The Homogeneous Part B is added, followed by the addition of KOH preheated (75ºC), cooling and degassing of the emulsion.
\newpage\ newpage
Ejemplo C3Example C3
La Parte A es calentada a 85ºC mientras se agita y luego se mezcla durante 30 segundos con una turbina a 8000 rev/minuto. Cuando esté homogénea, la Parte B es pre-calentada a 75ºC y se añade a la Parte A.Part A is heated to 85 ° C while stirring and then mix for 30 seconds with a turbine at 8000 rev / minute When it is homogeneous, Part B is pre-heated to 75 ° C and added to Part A.
La mezcla se enfría a 40ºC y la Parte C, se añade. La pérdida de agua se compensa y se continúa la agitación durante el enfriamiento a temperatura ambiente. Luego la mezcla es mezclada durante 30 segundos con una turbina a 8000 rev/minuto.The mixture is cooled to 40 ° C and Part C is Add. Water loss is compensated and stirring is continued during cooling to room temperature. Then the mixture is mixed for 30 seconds with a turbine at 8000 rev / minute.
La crema tiene una baja calidad de la penetración en la piel.The cream has a low quality of skin penetration
Claims (7)
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
\newpage\ newpage
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
\vskip1.000000\baselineskip\ vskip1.000000 \ baselineskip
\newpage\ newpage
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02008419 | 2002-04-12 | ||
EP02008419 | 2002-04-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2341441T3 true ES2341441T3 (en) | 2010-06-21 |
Family
ID=29225587
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES03746278T Expired - Lifetime ES2341441T3 (en) | 2002-04-12 | 2003-03-25 | ORGANOSILICIDE DERIVATIVES OF AMINO HIDROXIBENZOFENONAS AND ITS USE AS FILTERS OF UV-A RAYS IN COSMETIC PREPARATIONS. |
Country Status (11)
Country | Link |
---|---|
US (1) | US7388102B2 (en) |
EP (1) | EP1494642B1 (en) |
JP (1) | JP4349915B2 (en) |
KR (1) | KR100929303B1 (en) |
CN (1) | CN100424076C (en) |
AT (1) | ATE460152T1 (en) |
AU (1) | AU2003226709A1 (en) |
BR (1) | BRPI0309195B8 (en) |
DE (1) | DE60331637D1 (en) |
ES (1) | ES2341441T3 (en) |
WO (1) | WO2003086340A1 (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1874751A (en) * | 2003-11-05 | 2006-12-06 | Dsmip资产公司 | Light protecting composition with reduced total amount of uv filter containing a polysiloxane-based uv filter |
KR101123520B1 (en) * | 2003-12-04 | 2012-03-13 | 디에스엠 아이피 어셋츠 비.브이. | Microcapsules with uv filter activity and process for producing them |
KR101256248B1 (en) * | 2005-03-23 | 2013-04-18 | 디에스엠 아이피 어셋츠 비.브이. | Polysiloxane coated metal oxide particles |
JP2008545843A (en) * | 2005-05-31 | 2008-12-18 | ディーエスエム アイピー アセッツ ビー.ブイ. | New polysiloxane sunscreen. |
JP5294877B2 (en) * | 2006-02-09 | 2013-09-18 | チバ ホールディング インコーポレーテッド | Hydroxybenzophenone derivative |
JP5878783B2 (en) * | 2012-02-20 | 2016-03-08 | ポーラ化成工業株式会社 | Emulsified cosmetic |
CN105339344B (en) * | 2013-06-27 | 2018-04-20 | 帝斯曼知识产权资产管理有限公司 | The method for producing 2 (2 hydroxy benzoyl of 4 N, N dialkyl amido) benzoic ethers |
EP3013788B1 (en) | 2013-06-27 | 2019-02-27 | DSM IP Assets B.V. | Method for producing 2-(4-n,n-dialkylamino-2-hydroxybenzoyl) benzoates |
FR3015896B1 (en) * | 2013-12-31 | 2017-10-13 | Novance | SOLUBILIZATION OF UV FILTERS |
KR101833612B1 (en) * | 2016-03-30 | 2018-02-28 | 선진뷰티사이언스(주) | Polymer composite particles containing much of organic sunscreen agents and the method for preparing thereof |
CN110204668B (en) * | 2019-05-15 | 2021-09-24 | 大连理工大学 | Bis-hydrosilylation functionalized linear polymers suitable for hydrosilylation chemical reaction and preparation method thereof |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1527781A (en) | 1966-12-23 | 1968-06-07 | Rhone Poulenc Sa | New organosilicon compounds with ester functions |
US5270426A (en) * | 1990-01-22 | 1993-12-14 | Shin-Etsu Chemical Co., Ltd. | Organosilicon compound |
JP2527093B2 (en) * | 1990-09-25 | 1996-08-21 | 信越化学工業株式会社 | Organic silicon compounds and cosmetics |
FR2684551B1 (en) | 1991-12-05 | 1995-04-21 | Oreal | COSMETIC FILTERING OIL CONTAINING A FILTERED SILICONE AND A MIXTURE OF A VOLATILE SILICONE AND A SILICONE OIL OR A SILICONE GUM AND COSMETIC FILTERING EMULSION CONTAINING SUCH AN OIL. |
JP3428104B2 (en) | 1993-11-25 | 2003-07-22 | 株式会社資生堂 | Benzophenone derivatives, UV absorbers and skin external preparations |
FR2727115B1 (en) * | 1994-11-17 | 1996-12-27 | Oreal | NOVEL SOLAR FILTERS, PHOTOPROTECTIVE COSMETIC COMPOSITIONS CONTAINING THEM AND USES THEREOF |
US6114561A (en) | 1998-03-16 | 2000-09-05 | O'lenick, Jr.; Anthony J. | Silicone sunscreening esters |
FR2782516B1 (en) | 1998-08-21 | 2001-09-07 | Oreal | METHOD FOR PHOTOSTABILIZATION OF SOLAR FILTERS DERIVED FROM DIBENZOYLMETHANE, PHOTOSTABILIZED COSMETIC FILTERING COMPOSITIONS THUS OBTAINED AND THEIR USE |
DE19917906A1 (en) | 1999-04-20 | 2000-10-26 | Basf Ag | Use of amino-substituted hydroxybenzophenones as photostable UV filters in cosmetic and pharmaceutical preparations |
DE10012408A1 (en) * | 2000-03-15 | 2001-09-20 | Basf Ag | Use of sunscreen combinations which contain as essential constituent amino-substituted hydroxybenzophenones as photostable UV filters in cosmetic and pharmaceutical preparations |
DE10015086A1 (en) | 2000-03-28 | 2001-10-04 | Basf Ag | Textile fiber affine UV absorber mixture |
-
2003
- 2003-03-25 AT AT03746278T patent/ATE460152T1/en not_active IP Right Cessation
- 2003-03-25 US US10/511,020 patent/US7388102B2/en not_active Expired - Lifetime
- 2003-03-25 JP JP2003583364A patent/JP4349915B2/en not_active Expired - Fee Related
- 2003-03-25 AU AU2003226709A patent/AU2003226709A1/en not_active Abandoned
- 2003-03-25 ES ES03746278T patent/ES2341441T3/en not_active Expired - Lifetime
- 2003-03-25 WO PCT/EP2003/003095 patent/WO2003086340A1/en active Application Filing
- 2003-03-25 BR BRPI0309195A patent/BRPI0309195B8/en not_active IP Right Cessation
- 2003-03-25 DE DE60331637T patent/DE60331637D1/en not_active Expired - Lifetime
- 2003-03-25 CN CNB038083205A patent/CN100424076C/en not_active Expired - Fee Related
- 2003-03-25 KR KR1020047016207A patent/KR100929303B1/en active IP Right Grant
- 2003-03-25 EP EP03746278A patent/EP1494642B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP1494642B1 (en) | 2010-03-10 |
US20050255066A1 (en) | 2005-11-17 |
BR0309195A (en) | 2005-02-09 |
JP4349915B2 (en) | 2009-10-21 |
BRPI0309195B8 (en) | 2016-05-31 |
EP1494642A1 (en) | 2005-01-12 |
WO2003086340A1 (en) | 2003-10-23 |
CN1646091A (en) | 2005-07-27 |
BR0309195B1 (en) | 2014-02-11 |
ATE460152T1 (en) | 2010-03-15 |
CN100424076C (en) | 2008-10-08 |
AU2003226709A1 (en) | 2003-10-27 |
KR20040097336A (en) | 2004-11-17 |
DE60331637D1 (en) | 2010-04-22 |
KR100929303B1 (en) | 2009-11-27 |
JP2005539099A (en) | 2005-12-22 |
US7388102B2 (en) | 2008-06-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2269978T3 (en) | COMPOSITIONS FOR SOLAR FILTERS AND DIHYDROPIRIDINES AND DIHYDROPIRANS. | |
JP5015132B2 (en) | Metal oxide particles coated with polysiloxane | |
ES2350493T3 (en) | PARTICLES OF METAL OXIDE, COVERED WITH A CHROMOPHORE. | |
KR20120108043A (en) | 2-phenyl-1,2,3-benzotriazoles for uv radiation absorbance | |
ES2334797T3 (en) | LIGHT PROTECTIVE COMPOSITION WITH A REDUCED TOTAL AMOUNT OF UV FILTER CONTAINING A POLISILOXANE BASED UV FILTER. | |
ES2522894T3 (en) | Copolymers and their use in personal care compositions | |
ES2341441T3 (en) | ORGANOSILICIDE DERIVATIVES OF AMINO HIDROXIBENZOFENONAS AND ITS USE AS FILTERS OF UV-A RAYS IN COSMETIC PREPARATIONS. | |
KR101264456B1 (en) | Novel polysiloxane sunscreens | |
FR3006176A1 (en) | COMPOSITE PARTICLES BASED ON INORGANIC UV FILTER AND PERLITE; COSMETIC OR DERMATOLOGICAL COMPOSITIONS CONTAINING THEM | |
JP4565998B2 (en) | sunscreen | |
WO2015007146A1 (en) | Ultraviolet absorbent having better ultraviolet protection effect, and combination thereof | |
JP4205013B2 (en) | S-triazine derivatives containing three specific para-aminobenzalmalonate groups, photoprotective cosmetic compositions containing these derivatives, use of said s-triazine derivatives | |
CN114746070A (en) | Sunscreen compositions with multiple photoprotective UV filters | |
US8846010B2 (en) | Silicone compound and photoprotective personal care compositions comprising the same | |
FR2961207A1 (en) | Use of new or known 4-carboxy-2-pyrrolidinone derivatives in composition comprising, in medium, liquid fatty phase and lipophilic active agent, as solvent and as agent improving solubility of active agent, in liquid fatty phase | |
BRPI0500552B1 (en) | compound, cosmetic or dermatological composition and uses of a compound | |
WO2023156298A1 (en) | Cosmetic or dermatological composition comprising a merocyanine and a polyionic complex | |
FR2879454A1 (en) | SOLAR COMPOSITION COMPRISING AT LEAST ONE HYDROPHILIC UV FILTER AND AT LEAST ONE HYDROXYALKYLUREE | |
FR2879456A1 (en) | SOLAR COMPOSITION COMPRISING AT LEAST ONE LIPOPHILIC UV FILTER AND AT LEAST ONE HYDROXYALKYLUREE |